Molecular typing of enteroviruses: Current status and future requirements

Clinical Microbiology Reviews

Volumn 11, Issue 1, 1998, Pages 202-227

  Muir, Peter ^a,i   Kämmerer, Ulrike ^b   Korn, Klaus ^c   Mulders, Mick N ^d   Pöyry, Tuija ^e   Weissbrich, Benedikt ^f   Kandolf, Reinhard ^b   Cleator, Graham M ^g   Van Loon, Anton M ^d,h  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h Dept Obstet Gynaecol Acad H   (Netherlands)

ⁱ ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; NUCLEOTIDE;

COST; DNA HYBRIDIZATION; ENTEROVIRUS; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REVIEW; SEROTYPING; VIRUS CHARACTERIZATION; VIRUS CULTURE; VIRUS INFECTION;

ENTEROVIRUS; RNA VIRUSES;

EID: 0031962886     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.11.1.202     Document Type: Review

References (496)

1. Abbaszadegan, M., M. S. Huber, C. P. Gerba, and I. L. Pepper. 1993. Detection of enteroviruses in groundwater with the polymerase chain reaction. Appl. Environ. Microbiol. 59:1318-1324.
2. Abebe, A., B. Johansson, J. Abens, and Ö. Strannegård. 1992. Detection of enteroviruses in faeces by polymerase chain reaction. Scand. J. Infect. Dis. 24:265-273.
3. Abraham, R., T. Chonmaitree, J. McComhs, B. Prabhakar, P. T. Lo Verde, and P. L. Ogra. 1993. Rapid detection of poliovirus by reverse transcription and polymerase chain reaction amplification: application for differentiation between poliovirus and nonpoliovirus enteroviruses. J. Clin. Microbiol. 31:395-399.
4. Abzug, M. J. 1995. Perinatal enterovirus infections, p. 231-238. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
5. Abzug, M. J., H. L, Keyserling, M. L. Lee, M. J. Levin, and H. A. Rotbart. 1995. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin. Infect. Dis. 20:1201-1206.
6. Abzug, M. J., M. J. Levin, and H. A. Rotbart. 1993. Profile of enterovirus disease in the first two weeks of life. Pediatr. Infect. Dis. J. 12:820-824.
7. Abzug, M. J., M. Loeffelholz, and H. A. Rotbart. 1995. Diagnosis of neonatal enterovirus infection by polymerase chain reaction. J. Pediatr. 126: 447-450.
8. Agol, V., S. G. Drozdov, T. A. Ivannikova, M. S. Kolesnikova, M. B. Korolev, and E. A. Tolskaya. 1989. Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. J. Virol. 63:4034-4038.
9. Aintablian, N., R. D. Pratt, and M. H. Sawyer. 1995. Rapidly recurrent enteroviral meningitis in non-immunocompromised infants caused by different viral strains. J. Med. Virol. 47:126-129.
10. Alexander, J. P., L. Baden, M. A. Pallansch, and L. J. Anderson. 1994. Enterovirus 71 infections and neurologic disease - United States, 1977-1991. J. Infect. Dis. 169:905-908.
11. Alexander, J. P., Jr., L. E. Chapman, M. A. Pallansch, W. T. Stephenson, T. J. Török, and L. J. Anderson. 1993. Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team. J. Infect. Dis. 167:1201-1205.
12. Al-Nakib, W. 1993. Prospects for treatment and prevention of virally induced heart disease, p. 231-239. In J. E. Banatvala (ed.), Viral infections of the heart. Edward Arnold, London, United Kingdom.
13. Andino, R., G. E. Rieckhof, P. L. Achacoso, and D. Baltimore. 1993. Poliovirus RNA synthesis utilizes an RNA complex formed around the 5′-end of viral RNA. EMBO J. 12:3587-3598.
14. Ando, T., S. S. Monroe, J. R. Gentsch, Q. Jin, D. C. Lewis, and R. I. Glass. 1995. Detection and differentiation of antigenically distinct small round-structured viruses (Nonwalk-like viruses) by reverse transcription-PCR and Southern hybridization. J. Clin. Microbiol. 33:64-71.
15. Anonymous. 1993. Genomic analysis of type 3 wild poliovirus isolates in southern Alberta. Can. Commun. Dis. Rep. 19:96-99.
16. Archard, L. C., N. E. Bewles, P. O. Behan, E. J. Bell, and D. J. Doyle. 1988. Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J. R. Soc. Med. 81:326-329.
17. Archard, L. C., C. Freeke, P. Richardson, B. Meany, E. Olsen, P. Morgan-Capner, M. Rose, P. Taylor, N. Banner, M. Yacoub, and N. Bowles. 1988. Persistence of enterovirus RNA in dilated cardiomyopathy: a progression from myocarditis, p. 349-362. In H.-P. Schultheiss (ed.), New concepts in viral heart disease. Springer-Verlag KG, Berlin, Germany.
18. Armstrong, J. A., M. Edmonds, H. Nakazato, B. S. Phillips, and M. H. Vaughan. 1972. Polyadcnylic acid sequences in the virion RNA of poliovirus and eastern equine encephalitis virus. Science 176:526-528.
19. Arola, A., J. Santti, O. Ruuskanen, P. Halonen, and T. Hyypiä. 1996. Identification of enteroviruses in clinical specimens by competitive PCR followed by genetic typing using sequence analysis. J. Clin. Microbiol. 34:313-318.
20. Assaad, F., and W. C. Cockburn. 1972. Four-year study of WHO virus reports on enterovirus other than poliovirus. Bull. W. H. O. 46:329-336.
21. Assaad, F., and W. C. Cockburn. 1982. The relation between acute persisting spinal paralysis and poliomyelitis vaccine - results of a ten year enquiry. Bull. W. H. O. 60:231-242.
22. Ault, G. S., and G. L. Stoner. 1992. Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences. J. Gen. Virol. 73:2669-2678.
23. Bailly, J. L., A. M. Borman, H. Peigue-Lafeuille, and K. M. Kean. 1996. Natural isolates of ECHO virus type 25 with extensive variations in IRES sequences and different translational efficiencies. Virology 215:83-96.
24. Balanant, J., S. Guillot, A. Candrea, F. Delpeyroux, and R. Crainic. 1991. The natural genomic variability of polioviruses analysed by a restriction fragment length polymorphism assay. Virology 184:645-654.
25. Banatvala, J. E. 1987. Insulin-dependent (juvenile-onset, type 1) diabetes mellitus: Coxsackie B viruses revisited. Prog. Med. Virol. 34:33-54.
26. Barrett-Connor, E. 1985. Is insulin dependent diabetes mellitus caused by Coxsackie B infection? A review of the epidemiologic evidence. Rev. Infect. Dis. 7:207-215.
27. Bastis, D., S. Simonet, M. A. Patterson, and S. Neill. 1995. Identification of enteroviruses by indirect immunofluorescence using monoclonal antibodies. Clin. Diagn. Virol. 3:83-93.
28. Beck, M. A., P. C. Kolbeck, L. H. Rohr, Q. Shi, V. C. Morris, and O. A. Levander. 1994. Vitamin E deficiency intensifies the myocardial injury of Coxsackievirus B3 infection of mice. J. Nutr. 124:345-358.
29. Beck, M. A., P. C. Kolbeck, L. H. Rohr, Q. Shi, V. C. Morris, and O. A. Levander. 1994. Benign human enterovirus becomes virulent in selenium-deficient mice. J. Med. Virol. 43:166-170.
30. Beck, M. A., P, C. Kolbeck, Q. Shi, L. H. Rohr, V. C. Morris, and O. A. Levander. 1994. Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice. J. Infect. Dis. 170:351-357.
31. Beck, M. A., Q. Shi, V. C. Morris, and O. A. Levander. 1995. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1:433-436.
32. Bell, E. J., R. A. McCartney, D. Basquill, and A. K. R. Chaudhuri. 1986. μ-antibody capture ELISA for the rapid diagnosis of enterovirus infections in patients with aseptic meningitis. J. Med. Virol. 19:213-217.
33. Bendig, J. W. A., and P. Molyneaux. 1996. Sensitivity and specificity of (μ-capture ELISA for detection of enterovirus IgM. J. Virol. Methods 59: 23-32.
34. Bergelson, J. M., M. Chan, K. Solomon, N. F. St. John, H. Lin, and R. W. Finberg. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for many echoviruses. Proc. Natl. Acad. Sci. USA 91:6245-6249.
35. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adeno-viruses 2 and 5. Science 275:1320-1323.
36. Bergelson, J. M., N. St. John, S. Kawaguchi, M. Chan, H. Stubdal, J. Modlin, and R. W. Finberg. 1993. Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2. J. Virol. 67:6847-6852.
37. Berkovich, S., and M. Ressel. 1967. Effect of sex on susceptibility of adult mice to coxsackie B2 infection. Arch. Gesamte Virusforsch. 22:246-251.
38. Berlin, L. E., M. L. Rorabaugh, F. Heldrich, K. Roberts, T. Doran, and J. F. Modlin. 1993. Aseptic meningitis in infants <2 years of age: diagnosis and etiology. J. Infect. Dis. 168:888-892.
39. Bharucha, E. P., V. P. Mondkar, N. H. Wardia, P. F. Irani, and S. M. Katrak. 1972. Neurological complications of a new conjunctivitis. Lancet ii:970-971.
40. Bienkowska-Szewczyk, K., and E. Ehrenfeld. 1988. An internal 5′ noncoding region required for translation of poliovirus RNA in vitro. J. Virol. 62:3068-3072.
41. Bienz, K., D. Egger, T. Pfister, and M. Troxler. 1992. Structural and functional characterization of the poliovirus replication complex. J. Virol. 66: 2740-2747.
42. Birch, D. E., L. Kolmodin, J. Wong, G. A. Zangenberg, M. A. Zoccoli, N. McKinney, K. K. Y. Young, and W. J. Laird. 1996. Simplified hot start PCR. Nature 381:445-446.
43. Black, W. C., D. N. Vanlandingham, W. P. Sweeney, L. P. Wasieloski, C. H. Calisher, and B. J. Beaty. 1995. Typing of LaCrosse, snowshoe hare, and Tahyna viruses by analyses of single-strand conformation polymorphisms of the small RNA segments. J. Clin. Microbiol. 33:3179-3182.
44. Boivin, G., S. Chou, M. R. Quirk, A. Erice, and M. C. Jordan. 1996. Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J. Infect. Dis. 173:523-528.
45. Boman, J., B. Nilsson, and P. Juto. 1992. Serum IgA. IgG, and IgM responses to different enteroviruses as measured by a coxsackie B5-based indirect ELISA. J. Med. Virol. 38:32-35.
46. Bootman, J. S., and P. A. Kitchin. 1994. Reference preparations in the standardisation of HIV-1 PCR - an international collaborative study. J. Virol. Methods 49:1-8.
47. Böttiger, M., and E. Herrström. 1992. Isolation of polioviruses from sewage and their characteristics: experience over two decades in Sweden. Scand. J. Infect. Dis. 24:151-155.
48. Bouchard, M. J., D.-H. Lam, and V. R. Racaniello. 1995. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J. Virol. 69:4972-4978.
49. Bowles, N. E., P. J. Richardson, E. G. J. Olsen, and L. C. Archard. 1986. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet i:1120-1123.
50. Brandful, J. A., N. Takeda, T. Yoshii, K. Miyamura, J. A. Mingle, E. T. Addy, and S. Yamazaki. 1991. A study of the evolution of coxsackievirus A24 variant in Ghana by viral RNA fingerprinting analysis. Res. Virol. 142:57-65.
51. Brown, B. A., and M. A. Pallansch. 1995. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 39:195-205.
52. Caggana, M., P. Chan, and A. Ramsingh. 1993. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67:4797-4803.
53. Calvez, V., I. Pelletier, S. Borzakian, and F. Colbere-Garapin. 1993. Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells. J. Virol. 67:4432-4435.
54. Cambridge, G., C. G. C. MacArthur, A. P. Waterson, J. F. Goodwin, and C. M. Oakley. 1979. Antibodies to coxsackie B viruses in primary congestive cardiomyopathy. Br. Heart J. 41:692-696.
55. Cann, A. J., G. Stanway, P. J. Hughes, P. D. Minor, D. M. A. Evans, G. C. Schild, and J. W. Almond. 1984. Reversion to neurovirulence of the live attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res. 12: 7787-7792.
56. Cao, Y. Y., X. X. Yang, J. Li, L. P. Ren, W. H. Lin, Y. N. Guo, Z. W. Lu, and J. F. Li. 1985. Study on the etiology of hand, foot and mouth disease (HFMD) in China. Acta Acad. Med. Sin. 7:333-336.
57. Casas, I., P. E. Klapper, G. M. Cleator, J. E. Echevarria, A. Tenorio, and J. M. Echevarria. 1995. Two different PCR assays to detect enteroviral RNA in CSF samples from patients with acute aseptic meningitis. J. Med. Virol. 47:378-385.
58. Cello, J., A. Samuelson, P. Stålhandske, B. Svennerholm, S. Jeansson, and M. Forsgren. 1993. Identification of group-common linear epitopes in structural and nonstructural proteins of enteroviruses by using synthetic peptides. J. Clin. Microbiol. 31:911-916.
59. Chan, D., and G. W. Hammond. 1985. Comparison of serodiagnosis of group B coxsackie virus infections by an immunoglobulin M capture enzyme immunoassay versus microneutralization. J. Clin. Microbiol. 21:830-834.
60. Chang, K. H., P. Auvinen, T. Hyypiä, and G. Stanway. 1989. The nucleotide sequence of coxsackievirus A9: implications for receptor binding and enterovirus classification. J. Gen. Virol. 70:3269-3280.
61. Chang, K. H., C. Day, J. Walker, T. Hyypiä, and G. Stanway. 1992. The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD motif in VP1 is functionally significant. J. Gen. Virol. 73:621-626.
62. Chapman, N. M.. and S. Tracy. 1995. Can recombinant DNA technology provide useful vaccines against viruses which induce heart disease? Eur. Heart J. 16(Suppl. O):144-146.
63. Chapman, N. M., S. Tracy, C. J. Gauntt, and U. Fortmueller, 1990. Molecular detection and identification of enteroviruses by using enzymatic amplification and nucleic acid hybridization. J. Clin. Microbiol. 28:843-850.
64. Chayama, K., A. Tsubota, Y. Arase, S. Saitoh, I. Koida, K. Ikeda, T. Matsumoto, M. Kobayashi, S. Iwasaki, S. Koyama, T. Morinaga, and H. Kumada. 1993. Genotypic subtyping of hepatitis C virus. J. Gastroenterol. Hepatol. 8:150-156.
65. Cheingsong-Popov, R., S. Lister, D. Callow, P. Kaleebu, S. Beddows, and J. Weber. 1994. Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization. AIDS Res. Hum. Retroviruses 10:1379-1386.
66. Chezzi, C. 1996. Rapid diagnosis of poliovirus infection by PCR amplification. J. Clin. Microbiol. 34:1722-1725.
67. Chonmaitree, T., C. D. Baldwin, and H. L. Lucia. 1989. Role of the virology laboratory in diagnosis and management of patients with central nervous system disease. Clin. Microbiol. Rev. 2:1-14.
68. Chonmaitree, T., C. Ford, C. Sanders, and H. L. Lucia. 1988. Comparison of cell cultures for rapid isolation of enteroviruses. J. Clin. Microbiol. 26:2576-2580.
69. Chonmaitree, T., and L. Mann. 1995. Respiratory infections, p. 255-270. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
70. Chow, L. H., C. J. Gauntt, and B. M. McManus. 1991. Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage. Lab. Invest. 64:55-64.
71. Christodoulou, C., F. Colbère-Garapin, A. Macadam, L. F. Taffs, S. Marsden, P. Minor, and F. Horaud. 1990. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J. Virol. 64:4922-4929.
72. Chumakov, K. M., E. M. Dragunsky, L. P. Norwood, M. P. Douthitt, Y. Ran, R. E. Taffs, J. Ridge, and I. S. Levenbrook. 1994. Consistent selection of mutations in the 5′-untranslated region of oral poliovirus vaccine upon passaging in vitro. J. Med. Virol. 42:79-85.
73. Chumakov, K. M., L. P. Norwood, M. L. Parker, E. M. Dragunsky, Y. Ran, and I. S. Levenbrook. 1992. RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence. J. Virol. 66:966-970.
74. Chumakov, K. M., L. B. Powers, K. E. Noonan, and I. B. Roninson. 1991. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc. Natl. Acad. Sci. USA 88:199-203.
75. Chumakov, K. M., M. Voroshilova, L. Shindarov, I. Lavrova, L. Gracheva, G. Koroleva, S. Vasilenko, I. Brodvarova, M. Nikolova, S. Gyurova, M. Gacheva, G. Mitov, N. Ninov, E. Tsylka, I. Robinson, M. Frolova, V. Bashkirtsev, L. Martiyanova, and V. Rodin. 1979. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol. 60: 329-340.
76. Claas, E. C., M. J. Sprenger, G. E. Kleter, R. van Beek, W. G. Quint, and N. Masurel. 1992. Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction. J. Virol. Methods 39:1-13.
77. Clements, G. B., F. McGarry, C. Nairn, and D. N. Galbraith. 1995. The detection of enterovirus specific RNA in serum: the relationship to chronic fatigue. J. Med. Virol. 45:151-166.
78. Clewley, J. P. 1995. Derivation and interpretation of viral nucleotide sequences from clinical specimens. Rev. Med. Microbiol. 6:26-38.
79. Cohen-Abbo. A., B. S. Culley, E. C. Sannella, and P. F. Wright. 1995. Diagnostic tests for poliovirus infection: a comparison of neutralization and immunofluorescence for the identification and typing of stool isolates. J. Virol. Methods 52:35-39.
80. Colonno, R. J., P. I. Callahan, and W. J. Long. 1986. Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses. J. Virol. 57:7-12.
81. Conyn-van Spaendonck, M. A. E., P. M. Oostvogel, A. M. van Loon, J. K. van Wijngaarden, and D. Kromhout. 1996. Circulation of poliovirus during the poliomyelitis outbreak in the Netherlands in 1992-1993. Am. J. Epidemiol. 143:929-935.
82. Couderc, T., J. Hogle, H. Le Blay, F. Horaud, and B. Blondel. 1993. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of polypeplides VP1and VP2 located on the inner surface of the capsid protein shell. J. Virol. 67:3808-3817.
83. Couderc, T., C. Christodoulou, H. Kopecka, S. Marsden, L. F. Taffs, R. Crainic, and F. Horaud. 1989. Molecular pathogenesis of neural lesions induced by poliovirus type 1. J. Gen. Virol. 70:2907-2918.
84. Cova, L., H. Kopecka, M. Aymard, and M. Girard. 1988. Use of cRNA probes for the detection of enteroviruses by molecular hybridization. J. Med. Virol. 24:11-18.
85. Crainic, R., P. Couillin, B. Blondel, N. Cabau, A. Boue, and F. Horodniceanu. 1983. Natural variation of poliovirus neutralization epitopes. Infect. Immun. 41:1217-1225.
86. Dagan, R. 1996. Nonpolio enteroviruses and the febrile young infant: epidemiologic,clinical and diagnostic aspects. Pediatr. Infect. Dis. J. 15:67-71.
87. Dagan, R., J. A. Jenista, and M. A. Menegus. 1988. Association of clinical presentation, laboratory findings, and virus serotypes with the presence of meningitis in hospitalized infants with enterovirus infection. J. Pediatr. 113:975-978.
88. Dagan, R., J. A. Jenista, S. L. Prather, K. R. Powell, and M. A. Menegus. 1985. Viremia in hospitalised children with enterovirus infections. J. Pediatr. 106:397-401.
89. Dagan, R., and M. A. Menegus. 1986. A combination of four cell types for rapid detection of enteroviruses in clinical specimens. J. Med. Virol. 19: 219-228.
90. Dagan, R., and M. A. Menegus. 1995. Nonpolio enteroviruses and the febrile infant, p. 239-254. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
91. Dagan, R., S. L. Prather, K. R. Powell, and M. A. Menegus. 1983. Neutralizing antibodies to non-polio enteroviruses in human immune serum globulin. Pediatr. Infect. Dis. J. 2:454-456.
92. Dahllund, L., L. Nissinen, T. Pulli, V.-P. Hyttinen, G. Stanway, and T. Hyypiä. 1995. The genome of echovirus 11. Virus Res. 35:215-222.
93. Damen, M., H. T. M. Cuypers, H. L. Zaaijer, H. W. Reesink, W. P. Schaasberg, W. H. Gerlich, H. G. M. Niesters, and P. N. Lelie. 1996. International collaborative study on the second EUROHEP HCV-RNA reference panel. J. Virol. Methods 58:175-185.
94. Da Silva, E. E., M. A. Pallansch, B. P. Holloway, M. J. C. Oliveira, H. G. Schatmayr, and O. M. Kew. 1991. Oligonucleotide probes for the specific detection of the wild poliovirus type 1 and 3 endemic to Brazil. Intervirology 32:149-159.
95. Davidson, F., P. Simmonds, J. C. Ferguson, L. M. Jarvis, B. C. Dow, E. A. Follett, C. R. Seed, T. Krusius, C. Lin, G. A. Medgyesi, H. Kiyokawa, G. Olim, G. Duraisamy, T. Cuypers, A. A. Saeed, D. Teo, J. Conradie, M. C. Kew, M. Lin, C. Muchaprayoon, O. K. Ndimbie, and P.-L. Yap. 1995. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J. Gen. Virol. 76:1197-1204.
96. Day, C, H. Cumming, and J. Walker. 1989. Enterovirus-specific IgM in the diagnosis of meningitis. J. Infect. 19:219-228.
97. De, L., B. Nottay, C.-F. Yang, B. P. Holloway, M. Pallansch, and O. Kew. 1995. Identification of vaccine-related polioviruses by hybridization with specific RNA probes. J. Clin. Microbiol. 33:562-571.
98. De Leon, R., C. Shieh, S. Baric, and M. D, Sobsey. 1990. Detection of enteroviruses and hepatitis A virus in environmental samples by gene probes and polymerase chain reaction, p. 833-853. In Advances in water analysis and treatment. Proceedings of the Water Quality Technology Conference. American Water Works Association, Denver, Colo.
99. Delwart, E. L., M. P. Busch, M. L. Kalish, J. W. Mosley, and J, I. Mullins. 1995. Rapid molecular epidemiology of human immunodeficiency virus transmission. AIDS Res. Hum. Retroviruses 11:1081-1093.
100. Deng, M. Y., S. P. Day, and D. O. Cliver. 1994. Detection of hepatitis A in environmental samples by antigen-capture PCR. Appl. Environ. Microbiol. 60:1927-1933.
101. Deshpande, J. M., and K. H. Dave. 1991. Intratypic differentiation of poliovirus type 1 isolates. Indian J. Med. Res. 93:202-207.
102. De Villiers, E. M. 1994. Human pathogenic papillomavirus types: an update, p. 1-12. In H, zur Hausen (ed.), Human pathogenic papillomaviruses. Springer-Verlag KG, Berlin, Germany.
103. Diedrich, S., G, Driesel, and E. Schreier. 1995. Sequence comparison of echovirus type 30 isolates to other enteroviruses in the 5′ noncoding region. J. Med. Virol. 46:148-152.
104. Dietz, V., J. Andrus, J. M. Olive, S. Cochi, and C. Dequadros. 1995. Epidemiology and clinical characteristics of acute flaccid paralysis associated with non-polio enterovirus isolation - the experience in the Americas. Bull. W. H. O. 73:597-603.
105. Drebot, M. A., C. Y. Nguan, J. J. Campbell, S. H. S. Lee, and K. R. Forward. 1994. Molecular epidemiology of enterovirus outbreaks in Canada during 1991-1992: identification of echovirus 30 and coxsackievirus B1 strains by amplicon sequencing. J. Med. Virol. 44:340-347.
106. Dwyer, J. M., and K. Erlendsson. 1988. Intraventricular gamma-globulin for the management of enterovirus encephalitis. Pediatr. Infect. Dis. J. 7:530-533.
107. Easton, A. J., and R. P. Eglin. 1988. The detection of coxsackievirus RNA in cardiac tissue by in situ hybridization. J. Gen. Virol. 69:285-291.
108. Echevarría, J. E., A. Tenorio, A. M. Courouce, P. Leon, and J. M. Echevarría. 1994. Polymerase chain reaction can resolve some undefined cases of hepatitis B virus antigenic subtyping. J. Med. Virol. 42:217-223.
109. Egger, D., L. Pasamontes, M. Ostermayer, and K. Bien. 1995. Reverse transcription multiplex PCR for differentiation between polio- and enteroviruses from clinical and environmental samples. J. Clin. Microbiol. 33: 1442-1447.
110. Eichner, M., and K. Dietz. 1996. Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated? Am. J. Epidemiol. 143:816-822.
111. El-Hagrassy, M. M. O., D. J. Coltart, and J. E. Banatvala. 1980. Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. Lancet ii:1160-1162.
112. Erlendsson, K., T. Swartz, and J. M. Dwyer. 1985. Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin. N. Engl. J. Med. 312:351-353.
113. Ferguson, M., Y.-H. Qui, P. D. Minor, D. A. Magrath, M. Spitz, and G. C. Schild. 1982. Monoclonal antibodies specific to the Sabin vaccine strain of poliovirus type 3. Lancet i:122-124.
114. Figueroa, J. P., D. Ashley, D. King, and B. Hull. 1989. An outbreak of acute flaccid paralysis in Jamaica associated with echovirus type 22. J. Med. Virol. 29:315-319.
115. Flanegan, J. B., R. F. Petterson, V. Ambros, M. J. Hewlett, and D. Baltimore. 1977. Covalent linkage of a protein to a denned nucleotide sequence at the 5′ terminus of virion and replicative intermediate RNAs of poliovirus. Proc. Natl. Acad. Sci. USA 74:961-965.
116. Fredericks, D. N., and D. A. Relman. 1996. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 9:18-33.
117. Freistadt, M. S., and K. E. Eberle. 1996. Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence. J. Virol. 70:6486-6492.
118. Frenkel, L. M., L. E. Wagner, Jr., S. M. Atwood, T. J. Cummins, and S. Dewhurst. 1995. Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine. J. Clin. Microbiol. 33:342-347.
119. Frisk, G., E. G. Torfason, and H. Diderholm. 1984. Reverse radioimmunoassays of IgM and IgG antibodies to coxsackie B viruses in patients with acute myopericarditis. J. Med. Virol. 14:191-200.
120. Fujimura, Y., S. Ishimoto, T. Shimoyama, N. Narita, Y. Kuze, A. Yoshioka, H. Fukui, T. Tanaka, F. Tsuda, H. Okamoto, Y. Miyakawa, and M. Mayurni. 1996. Genotypes and multiple infections with hepatitis C virus in patients with haemophilia A in Japan. J. Viral Hepatitis 3:79-84.
121. Fujioka, S., H. Koide, Y. Kitaura, H. Duguchi, and K. Kawamura. 1995. Analysis of enterovirus genotypes using single-strand conformation polymorphisms of polymerase chain reaction products. J. Virol. Methods 51: 253-258.
122. Furione, M., S. Guillot, D. Otelea, J. Balanant, A. Candrea, and R. Crainic. 1993. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196:199-208.
123. Galbraith, D. N., C. Nairn, and G. B. Clements. 1995. Phylogenetic analysis of short enteroviral sequences from patients with chronic fatigue syndrome. J. Gen. Virol. 76:1701-1707.
124. Gatmaitan, B. G., J. L. Chason, and A. M. Lerner. 1970. Augmentation of the virulence of murine coxsackievirus B3 myocardiopathy by exercise. J. Exp. Med. 131:1121-1136.
125. Gauntt, C. J., and M. A. Pallansch. 1996. Coxsackievirus B3 clinical isolates and murine myocarditis. Virus Res. 41:89-99.
126. Gear, J. H. S. 1984. Non polio causes of polio-like paralytic syndromes. Rev. Infect. Dis. 6:S379-S384.
127. Georgescu, M.-M., F. Delpeyroux, M. Tardy-Panit, J. Balanant, M. Combiescu, A. A. Combiescu, S. Guillot, and R. Crainic. 1994. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J. Virol. 68:8089-8101.
128. Gerba, C. P. 1981. Virus survival in wastewater treatment, p. 39-48. In M. Goddard and M. Butler (ed.), Viruses and waste water treatment. Pergamon Press, Oxford, United Kingdom.
129. Gingeras, T. R., P. Prodanovich, T. Latimer, J. C. Guatelli, D. D. Richman, and K. J. Barringer. 1991. Use of self-sustained sequence replication amplification reaction to analyze and detect mutations in zidovudine-resistant human immunodeficiency virus. J. Infect. Dis. 164:1066-1074.
130. Gjøen, K., A. L. Bruu, and I. ørstavik. 1996. Intratypic genome variability of echovirus type 30 in part of the VP4/VP2 coding region. Arch. Virol. 141:901-908.
131. Glikmann, G., M. Pedersen, and I. Pedersen. 1987. Intratypic differentialion of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 2 and poliovirus type 3. J. Virol. Methods 18:25-36.
132. Glimåker, M., A. Abebe, B. Johansson, A. Ehrnst, P. Olcén, and Ö. Strannegard. 1992. Detection of enteroviral RNA by polymerase chain reaction in faecal samples from patients with aseptic meningitis. J. Med. Virol. 38:54-61.
133. Glimåker, M., B. Johansson, P. Olcén, A. Ehrnst, and M. Forsgren. 1992. Detection of enteroviral RNA by polymerase chain reaction in cerebrospinal fluid from patients with aseptic meningitis. Scand. J. Infect. Dis. 25: 547-557.
134. Goldwater, P. N. 1995, Immunoglobulin M capture immunoassay in investigation of coxsackievirus B5 and B6 outbreaks in South Australia. J. Clin. Microbiol. 33:1628-1631.
135. Gouvea, V., R. I. Glass, P. Woods, K. Taniguchi, H. F. Clark, B. Forrester, and Z.-Y. Fang. 1990. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J. Clin. Microbiol. 28:276-282.
136. Gow, J. W., W. M. H. Behan, G. B. Clements, C. Woodall, M. Riding, and P. O. Behan. 1991. Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. Br. Med. J. 302:692-696.
137. Graff, J., J. Ticehurst, and B. Flehmig. 1993. Detection of hepatitis A virus in sewage sludge by antigen capture polymerase chain reaction. Appl. Environ. Microbiol. 59:3165-3170.
138. Grandien, M., M. Forsgren, and A. Ehrnst. 1995. Enteroviruses, p. 279-297. In E. H. Lennette, D. A. Lennette, and E. T. Lennette (ed.), Diagnostic procedures for viral, rickettsial, and chlamydial infections, 7th ed. American Public Health Association, Washington, D.C.
139. Gratsch, T. E., and V. F. Righthand. 1994. Construction of a recombinant cDNA of echovirus 6 that established a persistent in vitro infection. Virology 201:341-348.
140. Green, K. Y., J. F. Sears, K. Taniguchi, K. Midthun, Y. Hoshino, M. Gorziglia, K. Nishikawa, S. Urasawa, A. Z. Kapikian, R. M. Chanock, and J. Flores. 1988. Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene. J. Virol. 62:1819-1823.
141. Grinde, B., T. O. Jonassen, and H. Ushijima. 1995. Sensitive detection of group A rotaviruses by immunomagnetic separation and reverse transcription-polymerase chain reaction. J. Virol. Methods 55:327-338.
142. Grist, N. R. 1977. Coxsackie virus infections of the heart, p. 141-150. In A. P. Waterson (ed.), Recent advances in clinical virology 1. Churchill Livingstone, Edinburgh, United Kingdom,
143. Grist, N. R., and E. J. Bell. 1970. Enteroviral etiology of the paralytic poliomyelitis syndrome. Arch. Environ. Health 21:382.
144. Grist, N. R., and E. J. Bell. 1984. Paralytic poliomyelitis and nonpolio enteroviruses: studies in Scotland. Rev. Infect. Dis. 6:S385-S386.
145. Grist, N. R., E. J. Bell, and F. Assaad. 1978. Enteroviruses in human disease. Prog. Med. Virol. 24:114-157.
146. Grodums, E. I., and G. Dempster. 1959. The age factor in experimental coxsackie B3 infection. Can. J. Microbiol. 5:595-603.
147. Guillot, S., D. Otelea, F. Delpeyroux, and R. Crainic. 1994. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction. Vaccine 12:503-507.
148. Guo, J., T. Kitamura, H. Ebihara, C. Sugimoto, T. Kunitake, J. Takehisa, Y. Qun Na, M. N. Al-Ahadi, A. Hallin, K. Kawabe, F. Taguchi, and Y. Yogo. 1996. Geographical distribution of the human polyomavirus JC virus types A and B and isolation of a new type from Ghana. J. Gen. Virol. 77:919-927.
149. Haarmann, C. M., P. L. Schwimmbeck, T. Mertens, H. P. Schultheiss, and B. E. Strauer. 1994. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology 200:381-389.
150. Haddad, J., J. P. Gut, M. J. Wending, D. F. Astruc, M. Jernite, G. Obert, and J. Messer. 1993. Enterovirus infections in neonates. A retrospective study of 21 cases. Eur. J. Med. 2:209-214.
151. Hagiwara, A., I. Tagaya, and T. Yoneyama. 1978. Epidemic of hand, foot and mouth disease associated with enterovirus type 71 infection. Intervirology 9:60-63.
152. Haller, A. A., and B. L. Semler. 1992. Linker-scanning mutagenesis of the internal ribosome entry site of poliovirus RNA. J. Virol. 66:5075-5086.
153. Halonen, P., E. Rocha, J. Hierholzer, B. Holloway, T. Hyypiä, P. Hurskainen, and M. Pallansch. 1995. Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization. J. Clin. Microbiol. 33:648-653.
154. Hamby, B. B., M. A. Pallansch, and O. M. Kew. 1987. Reemergence of an epidemic coxsackievirus B5 genotype. J. Infect. Dis. 156:288-292.
155. Hanecak, R., B. L. Semler, C. W. Andersen, and E. Wimmer. 1982. Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc. Natl. Acad. Sci. USA 79:3973-3977.
156. Hanecak, R., B. L. Semler, H. Ariga, C. W. Andersson, and E. Wimmer. 1984. Expression of a cloned gene segment of poliovirus in E. coli: evidence for aulocatalytic production of the viral proteinase. Cell 37:1063-1073.
157. Hartig, P. C., and S. R. Webb. 1986. Coxsackievirus B4 heterogeneity: effect of passage on neutralization and mortaiity. Acta Virol. 30:475-486.
158. Heinz, B. A., and L. M. Vance. 1995. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus. J. Virol. 69:4189-4197.
159. Heinz, B. A., and L. M. Vance. 1996. Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses. J. Virol. 70:4854-4857.
160. Hellen, C. U. T., and E. Wimmer. 1995. Enterovirus genetics, p. 25-72. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
161. Hilton, D. A., S. Variend, and J. H. Pringle. 1993. Demonstration of coxsackie virus RNA in formalin-fixed sections from childhood myocarditis cases by in situ hybridization and the polymerase chain reaction. J. Pathol. 170:45-51.
162. Holland, J. J. 1961. Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 15:312-326.
163. Holland, J. J., J. C. De La Torre, and D. A. Steinhauer. 1992. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176:1-20.
164. Holland, J. J., K. Spindler, F. Horodyski, E. Grabau, S. Nichol, and S. Vandepol. 1982. Rapid evolution of RNA genomes. Science 215:1577-1585.
165. Holmes, E. C., L. Q. Zhang, P. Robertson, A. Cleland, E. Harvey, and P. Simmonds. 1995. The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J. Infect. Dis. 171:45-53.
166. Horstmann, D. M. 1950. Acute poliomyelitis. Relation of physical activity at the time of onset to the course of the disease. JAMA 142:236.
167. Hovi, T., K. Cantell, A. Huovilainen, E. Kinnunen, T. Kuronen, K. Lapinleimu, T. Pöyry, M. Roivainen, N. Salama, M. Stenvik, A. Silander, C.-J. Thoden, S. Salaminen, and P. Weckström. 1986. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet i:1427-1432.
168. Hovi, T., and M. Roivainen. 1993. Peptide antisera targeted to a conserved sequence in poliovirus capsid protein VP1 cross-react widely with members of the genus Enterovirus. J. Clin. Microbiol. 31:1083-1087.
169. Hovi, T., and M. Stenvik. 1994. Selective isolation of poliovirus in recombinant murine cell culture expressing the human poliovirus receptor gene. J. Clin. Microbiol. 32:1366-1368.
170. Hovi, T., M. Stenvik, and M. Rosenlew. 1996. Relative abundance of enterovirus serotypes in sewage differs from that in patients - clinical and epidemiologic implications. Epidemiol. Infect. 116:91-97.
171. Hu, D., D. Dong, E. Tang, M. Zhang, and Y. Cao. 1993. Antigenic analysis of coxsackievirus B3 with monoclonal antibodies. Jpn. J. Med. Sci. Biol. 46:87-93.
172. Hughes, M. S., E. M. Hoey, and P. V. Coyle. 1993. A nucleotide sequence comparison of coxsackievirus B4 isolates from aquatic samples and clinical specimens. Epidemiol. Infect. 110:389-398.
173. Hughes, P. J., D. M. A. Evans, P. D. Minor, G. C. Schild, J. W. Almond, and G. Stanway. 1986. The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland. J. Gen. Virol. 67:2093-2102.
174. Hughes, P. J., C. North, P. D. Minor, and G. Stanway. 1989. The complete nucleotide sequence of coxsackievirus A21. J. Gen. Virol. 70:2943-2952.
175. Huovilainen, A., L. Kinnunen, T. Pöyry, L. Laaksonen, M. Roivainen, and T. Hovi. 1994. Poliovirus type 3/Saukett: antigenic and structural correlates of sequence variation in the capsid proteins. Virology 199:228-232.
176. Huovilainen, A., M. N. Mulders, M. Agboatwalla, T. Pöyry, M. Stenvik, and T. Hovi. 1995. Genetic divergence of poliovirus strains isolated in the Karachi region of Pakistan. J. Gen. Virol. 76:3079-3088.
177. Huttunen, P., J. Santti, T. Pulli, and T. Hyypiä. 1996. The major echovirus group is genetically coherent and related to coxsackie B viruses. J. Gen. Virol. 77:715-725.
178. Hyypiä, T., P. Auvinen, and M. Maaronen. 1989. Polymerase chain reaction for human picornaviruses. J. Gen. Virol. 70:3261-3268.
179. Hyypiä, T., C. Horsnell, M. Maaronen, M. Khan, N. Kalkkinen, P. Auvinen, L. Kinnunen, and G. Stanway. 1992. A distinct picornavirus group identified by sequence analysis. Proc. Natl. Acad. Sci. USA 89:8847-8851.
180. Hyypiä, T., T. Hovi, N. J. Knowles, and G. Stanway. 1997. Classification of enteroviruses based on molecular and biological properties. J. Gen. Virol. 78:1-11.
181. Hyypiä, T., P. Stålhandske, R. Vainionpää, and U. Pettersson. 1984. Detection of enteroviruses by spot hybridization. J. Clin. Microbiol. 19:436-438.
182. Iizuka, N., S, Kuge, and A. Nomoto. 1987. Complete nucleotide sequence of the genome of coxsackievirus B1. Virology 156:64-73.
183. Ishiko, H., N. Takeda, K. Miyamura, N. Kato, M. Tanimura, K. H. Lin, M. Yin-Murphy, J. S. Tam, G. F. Mu, and S. Yamazaki. 1992. Phylogenetic analysis of a coxsackievirus A24 variant: the most recent worldwide pandemic was caused by progenies of a virus prevalent around 1981. Virology 187:748-759.
184. Ishiko, H., N. Takeda, K. Miyamura, M. Tanimura, T. Yamanaka, K. Kasuga, K. Oda, K. Imai, Y. Yamamoto, Y. Mochida, K. Uchida, H. Nakagawa, and S. Yamazaki. 1992. Phylogenelically different strains of a variant of coxsackievirus A 24 were repeatedly introduced but discontinued circulating in Japan. Arch. Virol. 126:179-193.
185. Jackson, J. B., J. Drew, H. J. Lin, P. Otto, J. W. Bremer, F. B. Hollinger, and S. M. Wolinsky. 1993. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group, ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. J. Clin. Microbiol. 31:3123-3128.
186. Jacobson, S. J., D. A. M. Konings, and P. Sarnow. 1993. Biochemical and genetic evidence for a pseudoknot structure at the 3′ terminus of the poliovirus RNA genome and its role in viral RNA amplification. J. Virol. 67:2961-2971.
187. Jansen, R. W., G. Siegl, and S. M. Lemon. 1990. Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method. Proc. Natl. Acad. Sci. USA 87:2867-2871.
188. Japour, A. J., S. Welles, R. T. D'Aquila, V. A. Johnson, D. D. Richman, R. W. Coombs, P. S. Reichelderfer, J. O. Kahn, C. S. Crumpacker, and D. R. Kuritzkes. 1995. Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group. J. Infect. Dis. 171:1172-1179.
189. Jarzabek, Z., J, Zabicka, A. John, J. Howlett, G. Dunn, and D. J. Wood. 1992. Application of monoclonal antibody panels in the virological and epidemiological review of poliomyelitis in Poland, 1981-1990. Bull. W. H. O. 70:327-333.
190. Jenkins, O., J. B. Booth, P. D. Minor, and J. W. Almond. 1987. The complete nucleotide sequence of coxsackie B4 and its comparison to other members of the picornaviridae. J. Gen. Virol. 68:1835-1848.
191. Jin, L., P. E. Gibson, J. C. Booth, and J. P. Clewley. 1993. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products. J. Med. Virol. 41:11-17.
192. Johnston, S. L., G. Sanderson, P. K. Pattemore, S. Smith, P. G. Bardin, C. B. Bruce, P. R. Lambden, D. A. J. Tyrrell, and S. T. Holgate. 1993. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J. Clin. Microbiol. 31:111-117.
193. Johnston, S. L., and C. S. Siegel. 1990. Presumptive identification of enteroviruses with RD, HEp-2, and RMK cell lines. J. Clin. Microbiol. 28: 1049-1050.
194. Jung, M., H. Agut, D. Candotti, D. Ingrand, C. Katlama, and J. M. Huraux. 1992. Susceptibility of HIV-1 isolates to zidovudine: correlation between widely applicable culture test and PCR analysis. J. Acquired Immune Defic. Syndr. 5:359-364.
195. Kamel, N. N. 1992. A profile for molecular biology databases and information resources. Comput. Appl. Biosci. 8:311-321.
196. Kämmerer, U., B. Kunkel, and K. Korn. 1994. Nested polymerase chain reaction for specific detection and rapid identification of human picorna-viruses. J. Clin. Microbiol. 32:285-291.
197. Kandolf, R., A. Canu, K. Klingel, P. Kirschner, H. Schönke, J. Mertsching, R. Zell, and P. H. Hofschneider. 1990. Molecular studies on enteroviral heart disease, p. 340-348. In M. A. Brinton and F. X. Heinz (ed.), New aspects of positive-strand RNA viruses. American Society for Microbiology, Washington, D.C.
198. Kandolf, R., and P. H. Hofschneider. 1987. Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc. Natl. Acad. Sci. USA 84:6272-6276.
199. Kao, S.-Y., T. M. Niemiec, M. J. Loeffelholz, B. Dale, and H. A. Rotbart. 1995. Direct and uninterrupted RNA amplification of enteroviruses with colorimetric microwell detection. Clin. Diagn. Virol. 3:247-257.
200. Kaplan, M. H., S. W. Klein, J. McPhee, and R. G. Harper. 1983. Coxsackie virus infections in infants younger than three months of age: a serious childhood illness. Rev. Infect. Dis. 5:1019-1032.
201. Kapsenberg, J. G. 1988. Picornaviridae: the enteroviruses (polioviruses, coxsackieviruses, echoviruses), p. 692-722. In E. H. Lennette, P. Halonen, and F. A. Murphy (ed.), Laboratory diagnosis of infectious diseases. Principles and practice, vol. 2. Viral, rickettsial, and chlamydial diseases. Springer-Verlag, New York, N.Y.
202. Kapsenberg, J. G., A. Ras, and J. Korte. 1980. Improvement of enterovirus neutralization by treatment with sodium deoxycholate or chloroform. Intervirology 12:329-334.
203. Karnauchow, T. M., D, L. Tolson, B. A. Harrison, E. Altman, D. M. Lublin, and K. Dimock. 1996. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J. Virol. 70:5143-5152.
204. Kawamura, N., M. Kohara, S. Abe, T. Komatsu, K. Tago, M. Arita, and A. Nomoto. 1989. Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J. Virol. 63:1302-1309.
205. Kaye, S., C. Loveday, and R. S. Tedder. 1992. A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine. J. Med. Virol. 37:241-246.
206. Kew, O. M., M. N. Mulders, G. Y. Lipskaya, E. E. Dasilva, and M. A. Pallansch. 1995. Molecular epidemiology of polioviruses. Semin. Virol. 6:401-414.
207. Kew, O. M., B. K. Nottay, M. H. Hatch, J. C. Hierholzer, and J. F. Obijeski. 1983. Oligonucleotide fingerprint analysis of enterovirus 70 isolates from the 1980 to 1981 pandemic of acute hemorrhagic conjunctivitis: evidence for a close genetic relationship among Asian and American strains. Infect. Immun. 41:631-635.
208. Khan, M., H. Why, P. Richardson, and L. C. Archard. 1994. Nucleotide sequencing of polymerase chain reaction products shows the presence of Coxsackie-B3 virus in endomyocardial biopsies from patients with myocarditis or dilated cardiomyopathy. Biochem. Soc. Trans. 22:176S.
209. Khatib, R., J. L. Chason, B. K. Silberberg, and A. M. Lerner. 1980. Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. J. Infect. Dis. 141:394-403.
210. Kidd, A. H., M. Jönsson, D. Garwicz, A. E. Kajon, A. G. Wermenbol, M. J. Verweij, and J. C. de Jong. 1996. Rapid subgenus identification of human adenovirus isolates by a general PCR. J. Clin. Microbiol. 34:622-627.
211. Kilpatrick, D. R., B. Nottay, C.-F. Yang, S.-J. Yang, M. N. Mulders, B. P. Holloway, M. A. Pallansch, and O. M. Kew. 1996. Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J. Clin. Microbiol. 34:2990-2996.
212. Kim-Farley, R. J., K. J. Bart, L. B. Schonberger, W. A. Orenstein, B. M. Nkowane, A. R. Hinman, O. M. Kew, M. H. Hatch, and J. E. Kaplan. 1984. Poliomyelitis in the USA: virtual elimination of disease caused by wild virus. Lancet ii:1315-1317.
213. Kim-Farley, R., and the Expanded Programme on Immunization Team. 1992. Global immunization. Annu. Rev. Public Health 13:223-237.
214. Kimura, H., M. Shibata, K. Kuzushima, K. Nishikawa, Y. Nishiyama, and T. Morishima. 1990. Detection and direct typing of herpes simplex virus by polymerase chain reaction. Med. Microbiol. Immunol. 179:177-184.
215. Kinnunen, L., A. Huovilainen, T. Pöyry, and T. Hovi. 1990. Rapid molecular evolution of wild type 3 poliovirus during infection in individual hosts. J. Gen. Virol. 71:317-324.
216. Kinnunen, L., T. Pöyry, and T. Hovi. 1992. Genetic diversity and rapid evolution of poliovirus in human hosts. Curr. Top. Microbiol. Immunol. 176:49-61.
217. Kitamura, N., B. L. Semler, P. G. Rothberg, G. R. Larsen, C. J. Adler, A. J. Dorner, E. A. Emini, R. Hanecak, J. J. Lee, S. van der Werf, C. W. Anderson, and E. Wimmer. 1981. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 291:547-553.
218. Klespies, S. L., D. E. Cebula, C. L. Kelley, D. Galehouse, and C. C. Maurer. 1996. Detection of enteroviruses from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay. J. Clin. Microbiol. 34:1465-1467.
219. Klingel, K., and R. Kandolf. 1996. Molecular in situ localization techniques in diagnosis and pathogenicity studies of enteroviral heart disease. Clin. Diagn. Virol. 5:157-166.
220. Klingel, K., C. Hohenadl, A. Canu, M. Albrecht, M. Seemann, G. Mall, and R. Kandolf. 1992. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA 89: 314-318.
221. Klump, W. M., I. Bergmann, B. C. Muller, D. Ameis, and R. Kandolf. 1990. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J. Virol. 64:1573-1583.
222. Knowlton, K. U., E.-S. Joen, N. Berkley, R. Wessely, and S. Huber. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70:7811-7818.
223. Kogon, A., I. Spigland, T. G. Frothingham, L. Elveback, C. Williams, C. E. Hall, and J. P. Fox. 1969. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am. J. Epidemiol. 89:51-61.
224. Kok, P. W., J. Leeuwenburg, P. Tukei, A. L. van Wezel, J. G. Kapsenberg, G. van Steenis, A. Galazka, S. E. Robertson, and D. Robinson. 1992. Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya. Bull. W. H. O. 70:93-103.
225. Kono, R., K. Miyamura, E. Tajiri, A. Sasagawa, and P. Phuapradit. 1977. Virological and serological studies of neurological complications of acute hemorrhagic conjunctivitis in Thailand. J. Infect. Dis. 135:706-713.
226. Kono, R., K. Miyamura, E. Tajiri, S. Shiga, A. Sasagawa, P. F. Irani, S. M. Katrak, and N. H. Wadia. 1974. Neurologic complications associated with acute hemorrhagic conjunctivitis infection and its serologic confirmation. J. Infect. Dis. 129:590-593.
227. Kopecka, H., B. Brown, and M. Pallansch. 1995. Genotypic variation in coxsackievirus B5 isolates from three different outbreaks in the United States. Virus Res. 38:125-136.
228. Kopecka, H., S. Dubrou, J. Prevot, J. Marechal, and J. M. López-Pila. 1993. Detection of naturally occurring enteroviruses in waters by reverse transcription, polymerase chain reaction, and hybridization. Appl. Environ. Microbiol. 59:1213-1219.
229. Korn, K. Unpublished observation.
230. Kostrikis, L. G., Y. Cao, H. Ngai, J. P. Moore, and D. Ho. 1996. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J. Virol. 70:445-458.
231. Kozal, M. J., N. Shah, N. Shen, R. Yang, R. Fucini, T. C. Merigan, D. D. Richman, D. Morris, E. Hubbell, M. Chee, and T. R. Gingeras. 1996. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat. Med. 2:753-759.
232. Kraus, W., H. Zimmermann, A. Zimmermann, H. J. Eggers, and B. NelsenSalz. 1995. Infectious cDNA clones of echovirus 12 and a variant resistant against the uncoating inhibitor rhodanine differ in seven amino acids. J. Virol. 69:5853-5858.
233. La Monica, N., C. Meriam, and V. R. Racaniello. 1986. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J. Virol. 57:515-525.
234. La Monica, N., and V. R. Racaniello. 1989. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol. 53:2357-2360.
235. Lanciotti, R. S., C. H. Calisher, D. J. Gubler, G. J. Chang, and A. V. Vorndam. 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 30:545-551.
236. Lansdown, A. B. G. 1978. Viral infections and diseases of the heart. Prog. Med. Virol. 24:70-113.
237. Lee, T. W., B. Megson, and J. B. Kurtz. 1996. Enterovirus typing by immune electronmicroscopy. J. Med. Microbiol. 44:151-153.
238. Leparc, I., M, Aymard, and F. Fuchs. 1994. Acute, chronic and persistent enterovirus and poliovirus infections: detection of viral genome by semi-nested PCR amplification in culture-negative samples. Mol. Cell. Probes 8:487-495.
239. Li, J., L. B. Zhang, T. Yoneyama, H. Yoshida, H. Shimizu, K. Yoshii, M. Hara, T. Nomura, H. Yoshikura, T. Miyamura, and A. Hagiwara. 1996. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients. Arch. Virol. 141:1047-1054.
240. Li, Y., Y. Yang, and H. Chen. 1995. Detection of enteroviral RNA in paraffin-embedded myocardial tissue from patients with Keshan by nested PCR. Chin. Med. J. 75:344-345.
241. Lim, K. A., and M. Benyesh-Melnick. 1960. Typing of viruses by combination of antiserum pools. Application to typing of enteroviruses (Coxsackie and ECHO). J. Immunol. 84:309-317.
242. Lim, K. H., and M. Yin-Murphy. 1971. An epidemic of conjunctivitis in Singapore in 1970. Singapore Med. J. 12:247-249.
243. Lin, K. H., N. Takeda, K. Miyamura, S. Yamazaki, and C. W. Chen. 1991. The nucleotide sequence of 3C proteinase region of the coxsackievirus A24 variant: comparison of the isolates in Taiwan in 1985-1988. Virus Genes 5:121-131.
244. Lin, K. H., H. L. Wang, M. M. Sheu, W. L. Huang, C. W. Chen, C. S. Yang, N. Takeda, N. Kato, K. Miyamura, and S. Yamazaki. 1993. Molecular epidemiology of a variant of coxsackievirus A24 in Taiwan: two epidemics caused by phylogenetically distinct viruses from 1985 to 1989. J. Clin. Microbiol. 31:1160-1166.
245. Lindberg, A. M., R. L. Crowell, R. Zell, R. Kandolf, and U. Pettersson. 1992. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res. 24:187-196.
246. Lindberg, A. M., P. O. K. Stålhandske, and U. Pettersson. 1987. Genome of coxsackievirus B3. Virology 156:50-63.
247. Lipiskaya, G. Y. U., E. A. Cherkasova, G. I. Belova, S. V. Maslova, T. N. Kutateladze, S. G. Drozdov, M. N. Mulders, M. A, Pallaansch, O. M. Kew, and V. I. Agol. 1995. Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known polio-virus genotypes. J. Gen. Virol. 76:1687-1699.
248. Lipson, S. M., R. Walderman, P. Costello, and K. Szabo. 1988. Sensitivity of rhabdomyosarcoma and guinea pig embryo cell cultures to field isolates of difficult-to-cultivate group A coxsackieviruses. J. Clin. Microbiol. 26: 1298-1303.
249. Lisitsyn, N., N. Usitsyn, and M. Wigler. 1993. Cloning the differences between two complex genomes. Science 259:946-951.
250. Locher, F., V. V. Survanarayana, and J. D. Tratschin. 1995. Rapid detection and characterization of foot-and-mouth disease virus by restriction and nucleotide sequence analysis of PCR products. J. Clin. Microbiol. 33:440-444.
251. Loria, R. M., S. Kibrick, and G. Madge. 1976. Infection in hypercholesteremic mice with coxsackievirus B. J. Infect. Dis. 133:655-662.
252. Lyden, D., J. Olszewski, and S. Huber. 1987. Variation in susceptibility of Balb/c mice to coxsackievirus group B type 3-induced myocarditis with age. Cell. Immunol. 105:332-339.
253. Lyden, D. C., J. Olszewski, M. Feran, L. P. Job, and S. A. Huber. 1987. Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am. J. Pathol. 126:432-438.
254. Macadam, A. J., G. Ferguson, C. Arnold, and P. D. Minor. 1991. An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J. Virol. 65:5225-5231.
255. Macadam, A. J., D. M. Stone, J. W. Almond, and P. D. Minor. 1994. The 5′ noncoding region and virulence of poliovirus vaccine strains. Trends Microbiol. 2:449-454.
256. Magnius, L. O., L. H. Saleh, T. Vikerfors, and H. Norder. 1988. A solid-phase reverse immunosorbent test for the detection of enterovirus IgM. J. Virol. Methods 20:73-82.
257. Mapoles, J. E., D. L. Krah, and R. L. Crowell. 1985. Purification of a HeLa cell receptor protein for group B coxsackieviruses. J. Virol. 55:560-566.
258. Martin, A. B., S. Webber, F. J. Fricker, R. Jaffe, G. Demmler, D. Kearney, Y. H. Zhang, J. Bodurtha, B. Gelb, J. Ni, J. T. Bricker, and J. A. Towbin. 1994. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90:330-339.
259. Mason, P. W., E. Rieder, and B. Baxt. 1994. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA 91:1932-1936.
260. Mateu, M. G. 1995. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res. 38:1-24.
261. Matsumoto, T., O. Yamada, A. Itagaki, S. Ishida, T. Kamahora, and T. Kurimura. 1992. Rapid DNA diagnosis of herpes simplex virus serotypes. J. Virol. Methods 40:119-125.
262. McCartney, R. A., J. E. Banatvala, and E. J. Bell. 1986. Routine use of μ-antibody-capture ELISA for the serological diagnosis of coxsackie B virus infections. J. Med. Virol. 19:205-212.
263. McIntyre, J. P., and G. A. Keen. 1993. Laboratory surveillance of viral meningitis by examination of cerebrospinal fluid in Cape Town, 1981-9. Epidemiol. Infect. 111:357-371.
264. McKinney, R. E., S. L. Katz, and C. M. Wilfert. 1987. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev. Infect. Dis. 9:334-356.
265. McOmish, F., P. L. Yap, B. C. Dow, E. A. Follett, C. Seed, A. J. Keller, T. J. Cobain, T. Krusius, E. Kolho, R. Naukkarinen, C. Lin, C. Lai, S. Leong, G. A. Medgyesi, M. Héjjas, H. Kiyokawa, K. Fukada, T. Cuypers, A. A. Saeed, A. M. Al-Rasheed, M. Lin, and P. Simmonds. 1994. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J. Clin. Microbiol. 32:884-892,
266. McPhee, F. R. Zell, B. Y. Reimann, P. H. Hofschneider, and R. Kandolf. 1994. Characterization of the N-terminal part of the neutralizing antigenic site I of coxsackievirus B4 by mutation analysis of antigen chimeras. Virus Res. 34:139-151.
267. Mease, P. J., H. D. Ochs, and R. J. Wedgwood. 1981. Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia. N. Engl. J. Med. 304:1278-1281.
268. Melnick, J. L. 1984. Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev. Infect. Dis. 6:S387-S390.
269. Melnick, J. L. 1996. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p. 655-712. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
270. Melnick, J. L. 1996. Current status of poliovirus infections. Clin. Microbiol Rev. 9:293-300.
271. Melnick, J. L., V. Rennick, B. Hampil, N. J. Schmidt, and H. H. Ho. 1973. Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses. Bull. W. H. O. 48:263-268.
272. Melnick, J. L., N. J. Schmidt, B. Hampil, and H. H. Ho. 1977. Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 19 group A coxsackievirus serotypes. Intervirology 8:172-181.
273. Melnick, J. L., and I. L. Wimberly. 1985. Lyophilized combination pools of enterovirus equine antisera: new LBM pools prepared from reserves of antisera stored frozen for two decades. Bull. W. H. O. 63:543-550.
274. Mendelsohn, C. L., E. Wimmer, and V. R. Racaniello. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56:855-865.
275. Mewes, H. W., R. Doelz, and D. G. George. 1994. Sequence databases: an indispensable source for biotechnological research. J. Biotechnol. 35:239-256.
276. Meyer, R. F., and F. Brown. 1995. Sequence identification of antigenic variants in plaque isolates of foot-and-mouth disease virus. J. Virol. Methods 55:281-283.
277. Miller, N. A., H. A. Carmichael, B. D. Calder, P. O. Behan, E. J. Bell, R. A. McCartney, and F. C. Hall. 1991. Antibody to coxsackie B virus in diagnosing postviral fatigue syndrome. Br. Med. J. 302:140-143.
278. Minor, P. D. 1992. The molecular biology of poliovaccines. J. Gen. Virol. 73:3065-3077.
279. Minor, P., F. Brown, E. Domingo, E. Hoey, A. King, N. Knowles, S. Lemon, A. Palmenberg, R. R. Ruekert, G. Stanway, E. Wimmer, and M. YinMurphy. 1995. Picornaviridae, p. 329-336. In F. A. Murphy, C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo, and M. D. Summers (ed.), Virus taxonomy. Classification and nomenclature of viruses. Sixth report of the International Committee on Taxonomy of Viruses Virology Division, International Union of Microbiological Societies. Springer-Verlag, Vienna, Austria. (Arch. Virol. Suppl. 10.)
280. Minor, P. D., M. Ferguson, D. M. A. Evans, J. W. Almond, and J. P. Icenogle. 1986. Antigenic structure of polioviruses of serotypes 1, 2, and 3. J. Gen. Virol. 67:1283-1291.
281. Minor, P. D., A. John, M. Ferguson, and J. P. Icenogle. 1986. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion of primary vaccinee. J. Gen. Virol. 67:693-706.
282. Minor, P. D., G. C. Schild, M. Ferguson, A. Mackay, D. I. Magrath, A. John, P. J. Yates, and M. Spitz. 1982. Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping. J. Gen. Virol. 61:167-176.
283. Mirkovic, N., J. Schmidt, M. Yin-Murphy, and J. L. Melnick. 1974. Enterovirus etiology of the 1970 Singapore epidemic of acute conjunctivitis. Intervirology 4:119-127.
284. Miyamura, K., N. Takeda, M. Tanimura, T. Ogino, S. Yamazaki, C. W. Chen, K. H. Lin, S. Y. Lin, A. Ghafoor, and M. Murphy. 1990. Evolutionary study on the coxsackievirus A 24 variant causing acute hemorrhagic conjunctivitis by oligonucleotide mapping analysis of RNA genome. Arch. Virol. 114:37-51.
285. Miyamura, K., M. Tanimura, N. Takeda, R. Kono, and S. Yamazaki. 1986. Evolution of enterovirus 70 in nature: all isolates were recently derived from a common ancestor. Arch. Virol. 89:1-14.
286. Miyamura, K., K. Yamashita, S. Yamadera, N. Kato, M. Akatsuka, M. Hara, S. Inouye, and S. Yamazaki. 1992. Poliovirus surveillance: isolation of polioviruses in Japan, 1980-1991. A report of the National Epidemiological Surveillance of Infectious Agents in Japan. Jpn. J. Med. Sci. Biol. 45:203-214.
287. Modlin, J. F. 1995. Introduction, p. 1606-1613. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York, N.Y.
288. Modlin, J. F. 1995. Polioviruses, p. 1613-1620. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York, N.Y.
289. Modlin, J. F. 1995. Coxsackieviruses, echoviruses, and newer enteroviruses, p. 1620-1636. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York, N.Y.
290. Modlin, J. F. 1995. Poliomyelitis and poliovirus immunization, p. 195-220. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
291. Monceyron, C., and B. Grinde. 1994. Detection of hepatitis A virus in clinical and environmental samples by immunomagnetic separation and PCR. J. Virol. Methods 46:157-166.
292. Moore, J. P., Y. Cao, J. Leu, L. Qin, B. Korber, D. D. Ho, and the WHO and NIAID Networks for HIV Isolation and Characterization. 1996. Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J. Virol. 70:427-444.
293. Moore, M. 1982. From the Centers for Disease Control. Enteroviral disease in the United States, 1970-1979. J. Infect. Dis. 146:103-108.
294. Moore, M., M. H. Kaplan, J. McPhee, D. J. Bregman, and S. W. Klein. 1984. Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79. Public Health Rep. 99:515-522.
295. Morens, D. M., and M. A. Pallansch. 1995. Epidemiology, p. 3-23. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
296. Morens, D. M., M. A. Pallansch, and M. Moore. 1991. Polioviruses and other enteroviruses, p. 427-497. In R. B. Belshe (ed.), Textbook of human virology. Mosby Year Book, St. Louis, Mo.
297. Mori, J., and J. P. Clewley. 1994. Polymerase chain reaction and sequencing for typing rhinovirus RNA. J. Med. Virol. 44:323-329.
298. Morita, K., M. Tanaka, and A. Igarashi. 1991. Rapid identification of dengue virus serotypes by using polymerase chain reaction. J. Clin. Microbiol. 29:2107-2110.
299. Moss, E. G., R. E. O'Neill, and V. R. Racaniello. 1989. Mapping of attenuating sequences of an avirulent poliovirus type 2 strain. J. Virol. 63:1884-1890.
300. Muckelbauer, J. K., M. Kremer, I. Minor, G. Diana, F. J. Dutko, J. Groarke, D. C. Pevear, and M. G. Rossman. 1995. The structure of cox-sackievirus B3 at 3.5 Å resolution. Structure 3:653-667.
301. Muir, P., and L. C. Archard. 1994. There is evidence for persistent enterovirus infections in chronic medical conditions in humans. Rev. Med. Virol. 4:245-250.
302. Muir, P., F. Nicholson, M. Jhetam, S. Neogi, and J. E. Banatvala. 1993. Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens. J. Clin. Microbiol. 31:31-38.
303. Muir, P., F. Nicholson, S. J. Illavia, T. S. McNeil, J. F. Ajetunmobi, H. Dunn, W. G. Starkcy, K. N. Reetoo, N. R. B. Cary, J. Parameshwar, and J. E. Banatvala. 1996. Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy. Heart 76:243-249.
304. Muir, P., F. Nicholson, G. T. Spencer, J. F. Ajetunmobi, W. G. Starkey, M. Khan, L. C. Archard, N. J. Cairns, V. E. R. Anderson, P. N. Leigh, R. S. Howard, and J. E. Banatvala. 1996. Enterovirus infection of the central nervous system of humans: lack of association with chronic neurological disease. J. Gen. Virol. 77:1469-1476.
305. Muir, P., F. Nicholson, A. J. Tilzey, M. Signy, T. A. H. English, and J. E. Banatvala. 1989. Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet i:804-807.
306. Mulders, M. N., M. P. G. Koopmans, H. G. A. M. van der Avoort, and A. M. van Loon. 1995. Detection and characterization of polioviruses - the molecular approach, p. 137-156. In Y. Becker and G. Darai (ed.), PCR: protocols for diagnosis of human and animal virus diseases. Springer-Verlag KG, Berlin, Germany.
307. Mulders, M. N., G. Y. Lipskaya, H. G. A. M. van der Avoort, M. P. G. Koopmans, O. M. Kew, and A. M. van Loon. 1995. Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J. Infect. Dis. 171:1399-1405.
308. Mulders, M. N., A. M. van Loon, H. G. A. M. van der Avoort, J. H. J. Reimerink, A. Ras, T. M. Bestebroer, M. A. Drebot, O. M. Kew, and M. P. G. Koopmans. 1995. Molecular characterization of a wild poliovirus type 3 epidemic in the Netherlands (1992 and 1993). J. Clin. Microbiol. 33:3252-3256.
309. Makao, T., N. Enomoto, N. Takada, A. Takada, and T. Date. 1991. Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J. Gen. Virol. 72:2105-2112.
310. Narang, H. K., and A. A. Codd. 1980. Enterovirus typing by immune electron microscopy using low-speed centrifugation. J. Clin. Pathol. 33:191-194.
311. Nibbeling, R., J. H. J. Reimerink, M. Agboatwala, T. Naquib, A. Ras, P. Poelstra, H. G. A. M. van der Avoort, and A. M. van Loon. 1994. A poliovirus type-specific IgM antibody-capture enzyme-linked immunosorbent assay for the rapid diagnosis of poliomyelitis. Clin. Diagn. Virol. 2:113-126.
312. Nicholson, F., J. F. Ajetunmobi, M. Li, E. A. Shackleton, W. G. Starkey, S. J. Illavia, P. Muir, and J. E. Banatvala. 1995. Molecular detection and serotypic analysis of enterovirus RNA in archival specimens from patients with acute myocarditis. Br. Heart J. 74:522-527.
313. Nicholson, F., G. Meetoo, S. Aiyar, J. E. Banatvala, and P. Muir. 1994. Detection of enterovirus RNA in clinical samples by nested polymerase chain reaction for rapid diagnosis of enterovirus infection. J. Virol. Methods 48:155-166.
314. Nicholson, W. J., S. H. Black, P. Simmonds, C. W. Chung, D. Aw, and J. F. Peutherer. 1992. Comparison of hepatitis B virus subtyping of d/y determinants by radioimmunoprecipitation assay and the polymerase chain reaction. J. Med. Virol. 36:21-27.
315. Nkowane, B. M., S. G. F. Wassilak, and W. A. Orenstein. 1987. Vaccine-associated paralytic poliomyelitis. United States 1973 through 1984. JAMA 257:1335-1340.
316. Noel, J. S., T. W. Lee, J. B. Kurtz, R. I. Glass, and S. S. Monroe. 1995. Typing of human astroviruses from clinical isolates by enzyme immunoassay and nucleotide sequencing. J. Clin. Microbiol. 33:797-801.
317. Nomoto, A., T. Omata, H. Toyoda, S. Kuge, H. Horie, Y. Kataoka, Y. Genba, Y. Nakano, and N. Imura. 1982. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc. Natl. Acad. Sci. USA 79:5793-5797.
318. Nottay, B. K., O. M. Kew, M. H. Hatch, J. T. Heyward, and J. F. Obijeski. 1981. Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology 108:405-423.
319. O'Connell, J., R. Albin, D. Blum, P. Grint, and J. Sehartz. 1995. Development of antiviral agents for picornavirus infections, p. 419-434. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
320. Okamoto, H., S. Kobata, H. Tokita, T. Inoue, G. D. Woodfield, P. V. Holland, B. A. Al-Knawy, O. Uzunalimoglu, Y. Miyakawa, and M. Mayumi. 1996. A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene. J. Virol. Methods 57:31-45.
321. Okamoto, H., Y. Sugiyama, S. Okada, K. Kurai, Y. Akahane, Y. Sugai, T. Tanaka, K. Sato, F. Tsuda, Y. Miyakawa, and M. Mayumi. 1992. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73:673-679.
322. Okamoto, H., H. Tokita, M. Sakamoto, M. Horikita, M. Kojima, H. lizuka, and S. Mishiro. 1993. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J. Gen. Virol. 74:2385-2390.
323. Okamoto, H., F. Tsuda, H. Sakugawa, R. I. Sastrosoewignjo, M. Imai, Y. Miyakawa, and M. Mayumi. 1988. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J. Gen. Virol. 69:2575-2583.
324. Olive, D. M., S. Al-Mufti, W. Al-Mulla, M. A. Khan, A. Pasca, G. Stanway, and W. Al-Nakib. 1990. Detection and differentiation of picornaviruses in clinical samples following genomic amplification. J. Gen. Virol. 71:2141-2147.
325. Omata, T., M. Kohara, S. Kuge, T. Komatsu, S. Abe, B. L. Semler, A. Kameda, H. Itoh, M. Arita, E. Wimmer, and A. Nomoto. 1986. Genetic analysis of the attenuation phenotype of poliovirus type 1. J. Virol. 58:348-358.
326. Oostvogel, P. M., J. K. van Wijngaarden, H. G. van der Avoort, M. N. Mulders, M. A. Conyn-van Spaendonck, H. C. Rumke, G. van Steenis, and A. M. van Loon. 1994. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet 344:665-670.
327. Osterhaus, A. D. M. E., A. van Wezel, T. Hazendonk, F. Uytdehaag, J. Van Asten, and B. van Steenis. 1983. Monoclonal antibodies to polioviruses. Comparison of intratypic strain differentiation of polioviruses using monoclonal antibodies versus cross absorbed antisera. Intervirology 20:129-136.
328. Page, G. S., A. G. Mosser, J. M. Hogle, D. J. Filman, R. R. Rueckert, and M. Chow. 1988. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J. Virol. 62:1781-1794.
329. Pan American Health Organization. 1993. Strategies for the certification of the eradication of wild poliovirus transmission in the Americas. Bull. Pan Am. Health Organ. 27:287-296.
330. Paul, J. 1971. A history of poliomyelitis virus. Yale University Press, New Haven, Conn.
331. Pavio, N., M.-H. Buc-Caron, and F. Colbère-Garapin. 1996. Persistent poliovirus infection of human fetal brain cells. J. Virol. 70:6395-6401.
332. Peigue-Lafeuille, H., F. Fuchs, F. Gharabaghi, M. Chambon, and M. Aymard. 1990. Impact on routine diagnosis of echovirus infections of intra-typic differentiation and antigenic variation in echovirus type 25 studied by using monoclonal antibodies. J. Clin. Microbiol. 28:2291-2296.
333. Pelletier, J., G. Kaplan, V. R. Racaniello, and N. Sonenberg. 1988. Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5′ noncoding region. Mol. Cell. Biol. 8:1103-1112.
334. Pilipenko, E. V., V. M. Blinov, L. I. Romanova, A. N. Sinyakov, S. V. Malsova, and V. I. Agol. 1989. Conserved structural domains in the 5′ untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology 168:201-209.
335. Pilipenko, E. V., S. V. Maslova, A. N. Sinyakov, and V. I. Agol. 1992. Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures. Nucleic Acids Res. 20:1739-1745.
336. Pipkin, P. A., D. J. Wood, V. R. Racaniello, and P. D. Minor. 1993. Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro. J. Virol. Methods 41:333-340.
337. Pollard, S. R., G. Dunn, N. Cammack, P. D. Minor, and J. W. Almond. 1989. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. J. Virol. 63:4949-4951.
338. Power, J. P., E. Lawlor, F. Davidson, E. C. Holmes, P. L. Yap, and P. Simmonds. 1995. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 345:1211-1213.
339. Pöyry, T., T. Hyypiä, C. Horsnell, L. Kinnunen, T. Hovi, and G. Stanway. 1994. Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology 202:5313-5319.
340. Pöyry, T., L. Kinnunen, and T. Hovi. 1992. Genetic variation in vivo and proposed functional domains of the 5′ noncoding region of poliovirus RNA. J. Virol. 66:5313-5319.
341. Pöyry, T., M. Stenvik, and T. Hovi. 1988. Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. Appl. Environ. Microbiol. 54:371-374.
342. Pöyry, T., L. Kinnunen, T. Hyypiä, B. Brown, C. Horsnell, T. Hovi, and G. Stanway. 1996. Genetic and phylogenetic clustering of enteroviruses. J. Gen. Virol. 77:1699-1717.
343. Pöyry, T., L. Kinnunen, J. Kapsenberg, O. Kew, and T. Hovi. 1990. Type 3 poliovirus/Finland/1984 is genetically related to common Mediterranean strains. J. Gen. Virol. 71:2535-2541.
344. Prabhakar, B. S., M. V. Haspel, P. R. McClintock, and A. L. Notkins. 1982. High frequency of antigenic variants among naturally occurring human coxsackie B4 virus isolates identified by monoclonal antibodies. Nature 300:374-376.
345. Prather, S. L., R. Dagan, J. A. Jenista, and M. A. Menegus. 1984. The isolation of enteroviruses from blood: a comparison of four processing methods. J. Med. Virol. 14:221-227.
346. Prather, S. L., J. A. Jenista, and M. A. Menegus. 1984. The isolation of nonpolio enteroviruses from serum. Diagn. Microbiol. Infect. Dis. 2:353-357.
347. Prévot, J., S. Dubrou, and J. Maréchal. 1993. Detection of human hepatitis A virus in environmental water by an antigen-capture polymerase chain reaction method. Water Sci. Technol. 27:227-233.
348. Puig, M., J. Jofre, F. Lucena, A. Allard, G. Wadell, and R. Girones. 1994. Detection of adenoviruses and enteroviruses in polluted waters by nested PCR amplification. Appl. Environ. Microbiol. 60:2963-2970.
349. Pulli, T., P. Koskimies, and T. Hyypiä. 1995. Molecular comparison of coxsackie A virus serotypes. Virology 212:30-38.
350. Puthavathana, P., H. W. Lee, and C. Y. Kang. 1992. Typing of hantaviruses from five continents by polymerase chain reaction. Virus Res. 26:1-14.
351. Quint, W. G., R. A. Heijtink, J. Schirm, W. H. Gerlich, and H. G. Niesters. 1995. Reliability of methods for hepatitis B virus DNA detection. J. Clin. Microbiol. 33:225-228.
352. Raab de Verdugo, U., H.-C. Selinka, M. Huber, B. Kramer, J. Kellermann, P. H. Hofschneider, and R. Kandolf. 1995. Characterisation of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J. Virol. 69:6751-6757.
353. Racaniello, V. R., and D. Baltimore. 1981. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc. Natl. Acad. Sci. USA 78:4887-4891.
354. Ramsingh, A. I., M. Caggana, and S. Ronstrom. 1995. Genetic mapping of the determinants of plaque morphology of coxsackievirus B4. Arch. Virol. 140:2215-2226.
355. Ramsingh, A. I., and D. N. Collins. 1995. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. J. Virol. 69: 7278-7281.
356. Raska, K. 1983. Epidemiologic surveillance in the control of infectious disease. Rev. Infect. Dis. 5:1112-1117. (Editorial.)
357. Ravaggi, A., A. Zonaro, M. G. Marin, M. Puoti, A. Albertini, and E. Cariani. 1994. Distribution of viral genotypes in Italy determined by hepatitis C virus typing by DNA immunoassay. J. Clin. Microbiol. 32:2280-2284.
358. Redline, R. W., D. R. Genest, and B. Tycko. 1991. Detection of enteroviral infection in paraffin-embedded tissue by the RNA polymerase chain reaction technique. Am. J. Clin. Pathol. 96:568-571.
359. Reimann, B.-Y., R. Zell, and R. Kandolf. 1991. Mapping of a neutralizing antigenic site of coxsackievirus B4 by construction of an antigenic chimera. J. Virol. 65:3475-3480.
360. Ren, R., E. G. Moss, and V. R. Racaniello. 1991. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 66:1377-1382.
361. Rezapkin, G. V., K. M. Chumakov, Z. Lu, Y. Ran, E. M. Dragunsky, and I. S. Levenbook. 1994. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology 202:370-378.
362. Rezapkin, G. V., L. P. Norwood, R. E. Taffs, E. M. Dragunsky, I. S. Levenbook, and K. M. Chumakov. 1995. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Virology 211:377-384.
363. Rice, S. K., R. E. Heinl, L. L. Thornton, and S. M. Opal. 1995. Clinical characteristics, management strategies, and cost implications of a statewide outbreak of enterovirus meningitis. Clin. Infect. Dis. 20:931-937.
364. Richman, D. D., J. C. Guatelli, J. Grimes, A. Tsiatis, and T. Gingeras. 1991. Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction. J. Infect. Dis. 164:1075-1081.
365. Rico-Hesse, R., M. A. Pallansch, B. K. Nottay, and O. M. Kew. 1987. Geographic distribution of wild poliovirus type 1 genotypes. Virology 160: 311-322.
366. Rivera, V. M., J. D. Welsh, and J. V. Maizel. 1988. Comparative sequence analysis of the 5′ noncoding region of the enteroviruses and rhinoviruses. Virology 165:42-50.
367. Robinson, C. R., F. W. Doane, and A. J. Rhodes. 1958. Report of an outbreak of febrile illness with pharyngeal lesions and exanthems, Toronto, summer 1957 - isolation of group A Coxsackie virus. Can. Med. Assoc. J. 79:615-621.
368. Rodriguez, A., E. Martinez-Salas, J. Dopazo, M. Davila, J. C. Saiz, and F. Sobrino. 1992. Primer design for specific diagnosis by PCR of highly variable RNA viruses: typing foot-and-mouth disease virus. Virology 189:363-367.
369. Roivainen, M., M. Agboatwalla, M. Stenvik, T. Rysä, D. S. Akram, and T. Hovi. 1993. Intrathecal immune response and virus-specific immunoglobulin M antibodies in laboratory diagnosis of acute poliomyelitis. J. Clin. Microbiol. 31:2427-2432.
370. Roivainen, M., L. Piirainen, and T. Hovi. 1996. Efficient RGD-independent entry process of coxsackievirus A9. Arch. Virol. 141:1909-1919.
371. Roivainen, M., L. Piirainen, T. Hovi, J. Virtanen, T. Riikonen, J. Heino, and T. Hyypiä. 1994. Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 203:357-365.
372. Romero, J. R., and H. A. Rotbart. 1995. Sequence analysis of the down-stream 5′ nontranslated region of seven echovimses with different neurovirulence phenotypes. J. Virol. 69:1370-1375.
373. Rossmann, M. G., E. Arnold, J. W. Erickson, E. W. Frankenberger, P. J. Griffith, H. Hecht, J. E. Johnsson, G. Kramer, M. Luo, A. G. Mosser, R. R. Rueckert, B. Sherry, and G. Vriend. 1985. Structure of a common cold virus and functional relationship to other picornaviruses. Nature 317:145-153.
374. Rossouw, E., C. W. Tsilimigras, and B. D. Schoub. 1991. Molecular epidemiology of a coxsackievirus B3 outbreak. J. Med. Virol. 34:165-171.
375. Rota, J. S., J. L. Heath, P. A. Rota, G. E. King, M. L. Celma, J. Carabana, R. Fernandez-Munoz, D. Brown, L. Jin, and W. J. Bellini. 1996. Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J. Infect. Dis. 173:32-37.
376. Rotbart, H. A. 1990. Enzymatic RNA amplification of the enteroviruses. J. Clin. Microbiol. 28:438-442.
377. Rotbart, H. A. 1991. Nucleic acid detection systems for enteroviruses. Clin. Microbiol. Rev. 4:156-168.
378. Rotbart, H. A. 1995. Meningitis and encephalitis, p. 271-289. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
379. Rotbart, H. A. 1995. Enteroviral infections of the central nervous system. Clin. Infect. Dis. 20:971-981.
380. Rotbart, H. A., J. P. Kinsella, and R. L. Wasserman. 1990. Persistent enterovirus infection in culture-negative meningoencephalitis: demonstration by enzymatic RNA amplification. J. Infect. Dis. 161:787-791.
381. Rotbart, H. A., and J. R. Romero. 1995. Laboratory diagnosis of enteroviral infections, p. 401-418. In H. A. Rotbart (ed.), Human enterovirus infections. American Society for Microbiology, Washington, D.C.
382. Rotbart, H. A., M. H. Sawyer, S. Fast, C. Lewinski, N. Murphy, E. F. Keyser, J. Spadoro, S.-Y. Kao, and M. Loeffelholz. 1994. Diagnosis of enteroviral meningitis by using PCR with a colorimetric microwell detection assay. J. Clin. Microbiol. 32:2590-2592.
383. Rueckert, R. R. 1996. Picomaviridae: the viruses and their replication, p. 609-654. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
384. Rueckert, R. R., and E. Wimmer. 1984. Systematic nomenclature of picornavirus proteins. J. Virol. 50:957-959.
385. Ryan, M. D., O. Jenkins, P. J. Hughes, A. Brown, N. J. Knowles, D. Booth, P. D. Minor, and J. W. Almond. 1990. The complete nucleotide sequence of enterovirus type 70: relationships with other members of the picornaviridae. J. Gen. Virol. 71:2291-2299.
386. Saitoh-Inagawa, W., A. Oshima, K. Aoki, N. Itoh, K. Isobe, E. Uchio, S. Ohno, H. Nakajima, K. Hata, and H. Ishiko. 1996. Rapid diagnosis of adenoviral conjunctivitis by PCR and restriction fragment length polymorphism analysis. J. Clin. Microbiol. 34:2113-2116.
387. Samuelson, A., M. Forsgren, B. Johansson, B. Wahren, and M. Sallberg. 1994. Molecular basis for serological cross-reactivity between enteroviruses. Clin. Diagn. Lab. Immunol. 1:336-341.
388. Samuelson, A., M. Forsgren, and M. Sallberg. 1995. Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody. Clin. Diagn. Lab. Immunol. 2:385-386.
389. Samuelson, A., E. Skoog, and M. Forsgren. 1990. Aspects on the serodiagnosis of enterovirus infections by ELISA. Serodiagn. Immunother. Infect. Dis. 4:395-406.
390. Sattar, S. A. 1981. Viral survival in receiving waters, p. 91-108. In M. Goddard and M. Butler (ed.), Viruses and waste water treatment. Pergamon Press, Oxford, United Kingdom.
391. Schlesinger, Y., M. H. Sawyer, and G. A. Storch. 1994. Enteroviral meningitis in infancy: potential for polymerase chain reaction in patient management. Pediatrics 94:157-162.
392. Schmidt, N. F., R. W. Guenther, and E. H. Lennette. 1961. Typing of ECHO virus isolates by immune serum pools. The "Intersecting Serum Scheme." J. Immunol. 87:623-626.
393. Schmidt, N. J., H. H. Ho, and E. H. Lennette. 1975. Propagation and isolation of group A coxsaekieviruses in RD cells. J. Clin. Microbiol. 2:183-185.
394. Schmidt, N. J., E. H. Lennette, and H. H. Ho. 1974. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129:304-309.
395. Schnurr, D., M. Dondero, D. Holland, and J. Connor. 1996. Characterization of echovirus 22 variants. Arch. Virol. 141:1749-1758.
396. Schwaiger, A., F. Umlauft, K. Weyrer, C. Larcher, J. Lyons, V. Mühlberger, O. Dietze, and K. Grûnewald. 1993. Detection of enterovirus ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction. Am. Heart J. 126:406-410.
397. Schweiger, B., E. Schreier, B. Böthig, and J. M. López-Pila. 1994. Differentiation of vaccine and wild-type polioviruses using polymerase chain reaction and restriction enzyme analysis. Arch. Virol. 134:39-50.
398. Seah, C. L. K., V. T. K. Chow, and Y. C. Chan. 1995. Semi-nested PCR using NS3 primers for the detection and typing of dengue viruses in clinical serum specimens. Clin. Diagn. Virol. 4:113-120.
399. Seah, C. L. K., V. T. K. Chow, H. C. Tan, and Y. C. Chan. 1995. Rapid, single-step RT-PCR typing of dengue viruses using five NS3 gene primers. J. Virol. Methods 51:193-200.
400. Shafren, D. R., R. C. Bates, M. V. Agrez, R. L. Herd, G. F. Burns, and R. D. Barry. 1995. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 69:3873-3877.
401. Sharief, M. K., R. Hentges, and M. Ciardi. 1991. Intrathecal immune response in patients with the post-polio syndrome. N. Engl. J. Med. 325: 749-755.
402. Sharp, I. R., and G. Wadell. 1995. Adenoviruses, p. 287-308. In A. J. Zuckerman, J. E. Banatvala, and J. R. Pattison (ed.), Principles and practice of clinical virology, 3rd ed. John Wiley & Sons, Ltd., Chichester, United Kingdom.
403. Sheehy, N., and U. Desselberger. 1993. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains. J. Gen. Virol. 74:223-228.
404. Shimizu, H., D. P. Schnurr, and J. C. Burns. 1994. Comparison of methods to detect enteroviral genome in frozen and fixed myocardium by polymerase chain reaction. Lab. Invest. 71:612-616.
405. Shuber, A. P., V. J. Grondin, and K. W. Klinger. 1995. A simplified procedure for developing multiplex PCRs. Genome Res. 5:488-493.
406. Sidhu, M. K., A. Rashidbaigi, M. J. Liao, and D. Testa. 1995. Distinction between HIV-1 and HIV-2 nucleotide sequences by PCR and restriction enzyme analysis. BioTechniques 18:20-24.
407. Simmonds, P. 1995. Variability of hepatitis C virus. Hepatology 21:570-583.
408. Simmonds, P., A. Alberti, H. Alter, F. Bonino, D. W. Bradley, C. Brechot, J. T. Brouwer, S.-W. Chan, K. Chayama, D.-S. Chen, Q.-L. Choo, M. Colombo, H. T. M. Cuypers, T. Date, G. M. Dusheiko, J. I. Esteban, O. Fay, S. J. Hadziyannis, J. Han, A. Hatzakis, E. C. Holmes, H. Hotta, M. Houghton, B. Irvine, M. Kohara, J. A. Kolberg, G. Kuo, J. Y. N. Lau, P. N. Lelie, G. Maertens, F. McOmish, T. Miyamura, M. Misokami, A. Nomoto, A. M. Prince, H. W. Reesink, C. Rice, M. Roggendorf, S. W. Schalm, T. Shikata, K. Shimotohno, L. Stuyver, C. Trépo, A. Weiner, P. L. Yap, and M. S. Urdea. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
409. Simmonds, P., E. C. Holmes, T.-A. Cha, S.-W. Chan, F. McOmish, B. Irvine, E. Beall, P. L. Yap, J. Kolberg, and M. S. Urdea. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74:2391-2399.
410. Simmonds, P., K. A. Rose, S. Graham, S. W. Chan, F. McOmish, B. C. Dow, E. A. Folled, P. L. Yap, and H. Marsden. 1993. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J. Clin. Microbiol. 31:1493-1503.
411. Skinner, M. A., V. R. Racaniello, G. Dunn, J. Cooper, P. D. Minor, and J. W. Almond. 1989. New model for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also shows that RNA secondary structure is important in neurovirulence. J. Mol. Biol. 207:379-392.
412. Slater, P. E., W. A. Orenstein, A. Morag, A. Avni, R. Handsher, M. S. Green, C. Costin, A. Yarrow, S. Rishpon, O. Havkin, T. Ben-Zvi, O. M. Kew, M. Rey, I. Epstein, T. A. Swartz, and J. L. Melnick. 1990. Poliomyelitis outbreak in Israel in 1988: a report and two commentaries. Lancet 335: 1192-1198.
413. Sonenberg, N. 1990. Poliovirus translation. Curr. Top. Microbiol. Immunol. 161:23-47.
414. Stanway, G., P. J. Hughes, R. C. Mountford, P. Reeve, P. D. Minor, G. C. Schild, and J. W. Almond. 1984. Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon12a1b. Proc. Natl. Acad. Sci. USA 81:1539-1543.
415. Stanway, G., A. J. Cann, R. Hauptmann, P. Hughes, L. D. Clarke, R. C. Mountford, P. D. Minor, G. C. Schild, and J. W. Almond. 1983. The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res. 11:5629-5643.
416. Stanway, G., N. Kalkkinen, M. Roivainen, F. Ghazi, M. Khan, M. Smyth, O. Meurman, and T. Hyypiä. 1994. Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J. Virol. 68: 8232-8238.
417. Strikas, R. A., L. J. Anderson, and R. A. Parker. 1986. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J. Infect. Dis. 153:346-351.
418. Stuyver, L., R. Rossau, A. Wyseur, M. Duhamel, B. Vanderborght, H. van Heuverswyn, and G. Maertens. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J. Gen. Virol. 74:1093-1102.
419. Stuyver, L., A. Wyseur, W. van Arnheim, F. Hernandez, and G. Maertens. 1996. Second-generation line probe assay for hepatitis C virus genotyping. J. Clin. Microbiol. 34:2259-2266.
420. Supanaranond, K., N. Takeda, and S. Yamazaki. 1992. The complete nucleotide sequence of a variant of coxsackie virus A24, an agent causing acute haemorrhagic conjunctivitis. Virus Genes 6:149-158.
421. Taffs, R. E., K. M. Chumakov, G. V. Rezapkin, Z. Lu, M. Douthitt, E. M. Dragunsky, and I. S. Levenbook. 1995. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions. Virology 209:366-373.
422. Takeda, N., K. Sakae, M. Agboatwalla, S. Isomura, R. Hondo, and S. Inouye. 1994. Differentiation between wild and vaccine-derived strains of poliovirus by stringent microplate hybridization of PCR products. J. Clin. Microbiol. 32:202-204.
423. Takeda, N., M. Tanimura, and K. Miyamura. 1994. Molecular evolution of the major capsid protein VP1 of enterovirus 70. J. Virol. 68:854-862.
424. Tambini, G., J. K. Andrus, E. Marques, J. Boshell, M. Pallansch, C. A, de Quadros, and O. Kew. 1993. Direct detection of wild poliovirus circulation by stool surveys of healthy children and analysis of community waste water. J. Infect. Dis. 168:1510-1514.
425. Tardy-Panit, M., B. Blondel, A. Martin, F. Tekaia, F. Horaud, and F. Delpeyroux. 1993. A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J. Virol. 67:4630-4638.
426. Tatem, J. M., C. Weeks-Levy, A. Giorgiu, S. J. DiMichelle, E. J. Gargacz, V. R. Racaniello, and F. R. Cano. 1992. A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J. Virol. 66:3194-3197.
427. Tenorio, A., J. E. Echevarría, I. Casas, J. M. Echevarría, and E. Tabares. 1993. Detection and typing of human herpesviruses by multiplex polymerase chain reaction. J. Virol. Methods 44:261-269.
428. Thorén, A., and A. Widell. 1994. PCR for the diagnosis of enteroviral meningitis. Scand. J. Infect. Dis. 26:249-254.
429. Tisminetzky, S., M. Gerotto, P. Pontisso, L. Chemello, L. E. Prescott, K. A. Rose, F. Baralle, P. Simmonds, and A. Alberti. 1995. Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types. J. Virol. Methods 55:303-307.
430. Tokita, H., H. Okamoto, H. lizuka, J. Kishimoto, F. Tsuda, L. A. Lesmana, Y. Miyakawa, and M. Mayumi. 1996. Hepatitis C variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J. Gen. Virol. 77:293-301.
431. Torfason, E. G., G. Frisk, and H. Diderholm. 1984. Indirect and reverse radioimmunoassay and their apparent specificities in detection of antibodies to enteroviruses in human sera. J. Med. Virol. 13:13-18.
432. Toyoda, H., M. Kohara, Y. Kataoka, T. Suganuma, T. Omata, N. Imura, and A. Nomoto. 1984. Complete nucleotide sequences of all three poliovirus serotype genomes: implication for genetic relationships, gene function and antigenic determinants. J. Mol. Biol. 174:561-585.
433. Toyoda, H., M. J. H. Nicklin, M. G. Murray, C. W. Anderson, J. J. Dunn, F. W. Studier, and E. Wimmer. 1986. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell 45:761-770.
434. Trabelsi, A., F. Grattard, M. Nejmeddine, M. Aouni, T. Bourlet, and B. Pozzetto. 1995. Evaluation of an enterovirus group-specific anti-VP1 monoclonal antibody, 5-D8/1, in comparison with neutralization and PCR for rapid identification of enteroviruses in cell culture. J. Clin. Microbiol. 33: 2454-2457.
435. Tracy, S. 1984. A comparison of the genomic homologies in the coxsackievirus B group: use of fragments of the cloned coxsackievirus B3 genome as probes. J. Gen. Virol. 65:2167-2172.
436. Tracy, S., N. M. Chapman, J. Romero, and A. I. Ramsingh. 1996. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Trends Microbiol. 4:175-179.
437. Tsai, Y.-L., M. D. Sobsey, L. R. Sangermano, and C. J. Palmer. 1993. Simple method of concentrating enteroviruses and hepatitis A virus from sewage and ocean water for rapid detection by reverse transcriptase-polymerase chain reaction. Appl. Environ. Microbiol. 59:3488-3491.
438. Tsai, Y.-L., B. Tran, L. R. Sangermano, and C. J. Palmer. 1994. Detection of poliovirus, hepatitis A virus, and rotavirus from sewage and ocean water by triplex reverse transcriptase PCR. Appl. Environ. Microbiol. 60:2400-2407.
439. Tu, Z., N. M. Chapman, G. Hufnagel, S. Tracy, J. R. Romero, W. H. Barry, L. Zhao, K. Currey, and B. Shapiro. 1995. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. J. Virol. 69:4607-4618.
440. Tuke, P. W., P. Luton, and J. A. Garson. 1992. Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of 'nested' PCR products. J. Virol. Methods 40:163-173.
441. Udaykumar, A. Heredia, V. Soriano, R. Bravo, J. S. Epstein, and I. K. Hewlett. 1994. Enhanced diagnostic efficiency of the polymerase chain reaction by coamplification of multiple regions of HIV-I and HIV-2. J. Virol. Methods 49:37-46.
442. Vallejo, A., and A. García Sáiz. 1995, Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain reaction: application to clinical specimens. J. Virol. Methods 51:9-17.
443. Vandamme, A. M., K. Fransen, L. Debaisieux, D. Marissens, S. Sprecher, D. Vaira, A. T. Vandenhroucke, and C. Verhofstede. 1995. Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. J. Virol. Methods 51:305-316.
444. Van der Avoort, H. G. A. M., B. P. Hull, T. Hovi, M. A. Pallansch. O. M. Kew, R. Crainic, D. J. Wood, M. N. Mulders, and A. M. van Loon. 1995. Comparative study of five methods for intratypic differentiation of polioviruses. J. Clin. Microbiol. 33:2562-2566.
445. Van der Avoort, H. G. A. M., J. H. J. Reimerink, A. Ras, M. N. Mulders, and A. M. van Loon. 1995. Isolation of epidemic poliovirus from sewage during the 1992-3 type 3 outbreak in the Netherlands. Epidemiol. Infect. 114:481-491.
446. VanDevanter, D. R., P. Warrender, L. Bennett, E. R. Schultz, S. Coulter, R. L. Garber, and T. R. Rose. 1996. Detection and analysis of diverse herpesviral species by consensus primer PCR. J. Clin. Microbiol. 34:1666-1671.
447. Van Doorn, L.-J., B. Kleter, I. Pike, and W. Quint. 1996. Analysis of hepatitis C virus isolates by serotyping and genotyping. J. Clin. Microbiol. 34:1784-1787.
448. Van Dyke, T. A., and J. B. Flanegan. 1980. Identification of poliovirus polypeptide p63 as a soluble RNA-dependent RNA polymerase. J. Virol. 35:732-740.
449. Vangrysperre, W., and K. De Clercq. 1996. Rapid and sensitive polymerase chain reaction based detection and typing of foot-and-mouth disease virus in clinical samples and cell culture isolates, combined with a simultaneous differentiation with other genomically and/or symptomatically related viruses. Arch. Virol. 141:331-344.
450. Van Loon, A. M., G. M. Cleator, and A. Ras for the European Union Concerted Action on Virus Meningitis and Encephalitis. External quality assessment of enterovirus detection and typing. Bull. W. H. O., in press.
451. Van Loon, A. M., A. Ras, P. Poelstra, M. Mulders, and H. van der Avoort. 1993. Intratypic differentiation of polioviruses, p. 359-369. In E. Kurstak (ed.), Measles and poliomyelitis. Springer-Verlag KG, Vienna, Austria.
452. Van Wezel, A. L., and A. G. Hazendonk. 1979. Intratypic serum differentiation of poliomyelitis virus strains by strain-specific antisera. Intervirology 11:2-8.
453. Viazov, S., A. Zibert, K. Ramakrishnan, A. Widell, A. Cavicchini, E. Schreier, and M. Roggendorf. 1994. Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J. Virol. Methods 48:81-91.
454. Vonsover, A., R. Handsher, M. Neuman, S. Guillot, J. Balanant, H. Rudich, E. Mendelson, T. Swartz, and R. Crainic. 1993. Molecular epidemiology of type 1 polioviruses isolated in Israel and defined by restriction fragment length polymorphism assay. J. Infect. Dis. 167:199-203.
455. Voroshilova, M. K., and M. P. Chumakov. 1959. Poliomyelitis-like properties of AB-IV-coxsackie A7 group of viruses. Prog. Med. Virol. 2:106-170.
456. Wadia, N. H., S. M. Katrak, V. P. Misra, P. N. Wadia, K. Miyamura, K. Hashimoto, T. Ogino, T. Hikiji, and R. Kono. 1983. Polio-like motor paralysis associated with acute hemorrhagic conjunctivitis in an outbreak in 1981 in Bombay, India: clinical and serologicstudies. J. Infect. Dis. 147: 660-668.
457. Wallis, C., and J. L. Melnick. 1967. Virus aggregation as the cause of the nonneutralizable persistent fraction. J. Virol. 1:478-488.
458. Ward, C. D., and J. B. Flanegan. 1992. Determination of the poliovirus RNA polymerase error frequency at eight sites in the viral genome. J. Virol 66:3784-3793.
459. Webb, S. R., K. P. Kearse, C. L. Foulke, P. C. Hartig, and B. S. Prabhakar. 1986. Neutralization epitope diversity of coxsackievirus B4 isolates detected by monoclonal antibodies. J. Med. Virol. 20:9-15.
460. Wecker, I., and V. ter Meulen. 1977. RD cells in the laboratory diagnosis of enteroviruses. Med. Microbiol. Immunol. 163:233-240.
461. Wenner, H. A. 1973. Virus diseases associated with cutaneous eruptions. Prog. Med. Virol. 16:269-336.
462. Werner, G., B. Rosenwirth, E. Bauer, J.-M. Seifert, F.-J. Werner, and J. Besemer. 1986. Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses. J. Virol. 57:1084-1093.
463. Westrop, G. D., K. A. Wareham, D. M. A. Evans, G. Dunn, P. D. Minor, D. I. Magrath, F. Taffs, S. Marsden, M. A. Skinner, G. C. Schild, and J. W. Almond. 1989. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J. Virol. 63:1338-1344.
464. WHO Network for HIV Isolation and Characterization. 1994. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral variants. AIDS Res. Hum. Retroviruses 10:1387-1400.
465. Woodall, C. J., M. H. Riding, D. I. Graham, and G. B. Clements. 1994. Sequences specific for enteroviruses detected in spinal cord from patients with motor neurone disease. Br. Med. J. 308:1541-1543.
466. Woodall, C. J., N. J. Watt, and G. B. Clements. 1993. Simple technique for detecting RNA viruses in single sections of wax embedded tissue. J. Clin. Pathol. 46:276-277.
467. Woodruff, J. F. 1970. The influence of post-weaning undernutrition on coxsackievirus B-3 infection of adult mice. I. Viral persistence and increase in severity of lesions. J. Infect. Dis. 121:137-163.
468. Woodruff, J. F. 1970. The influence of post-weaning undernutrition on coxsackievirus B-3 infection of adult mice. II. Alteration of host defence mechanisms. J. Infect. Dis. 121:164-181.
469. World Health Assembly. 1988. Global eradication of poliomyelitis by the year 2000. Resolution WHA41.28. World Health Organization, Geneva, Switzerland.
470. World Health Organization. 1981. Markers of poliovirus strains isolated from cases temporally associated with the use of live poliovirus vaccine. Report on a WHO collaborative study. J. Biol. Stand. 9:163-185.
471. World Health Organization. 1990. Manual for the virological investigation of poliomyelitis. World Health Organization, Geneva, Switzerland.
472. Wright, K. E., G. A. R. Wilson, D. Novosad, C. Dimock, D. Tan, and J. M. Weber. 1995. Typing and subtyping of influenza viruses in clinical samples by PCR. J. Clin. Microbiol. 33:1180-1184.
473. Wright, P. F., R. J. Kim Farley, C. A. de Quadros, S. E. Robertson, R. M. Scott, N. A. Ward, and R. H. Henderson. 1991. Strategies for the global eradication of poliomyelitis by the year 2000. N. Engl. J. Med. 325:1774-1779.
474. Wu, J.-C., K.-B. Choo, C-M. Chen, T.-Z. Chen, T.-I. Huo, and S.-D. Lee. 1995. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet 346:939-941.
475. Wyatt, H. V. 1973. Poliomyelitis in hypogammaglobulinemics. J. Infect. Dis. 128:802.
476. Yamazaki, K., I. Oishi, and Y. Minekawa. 1995. Nucleotide sequence analysis of recent epidemic strains of enterovirus 70. Microbiol. Immunol. 39:429-432.
477. Yang, C. F., L. De, B. P. Holloway, M. A. Pallansch, and O. M. Kew. 1991. Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res. 20:159-179.
478. Yang, C. F., L. De, S. J. Yang, J. Ruiz-Gómez, J. R. Cruz, B. P. Holloway, M. A. Pallansch, and O. M. Kew. 1992. Genotype-specific in vitro amplifications of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus. Res. 24:277-296.
479. Yerly, S., A. Gervaix, V. Simonet, M. Caflisch, L. Perrin, and W.
480. Yogo, Y., T. Iida, F. Taguchi, H. T. Kitamura, and Y. Aso. 1991. Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms. J. Clin. Microbiol. 29:2130-2138.
481. Yolken, R. H., and V. M. Torsch. 1981. Enzyme-linked immunosorbent assay for detection and identification of coxsackieviruses A. Infect. Immun. 31:742-750.
482. Yoon, J. W. 1990. The role of viruses and environmental factors in the induction of diabetes. Curr. Top. Microbiol. Immunol. 164:95-123.
483. Yousef, G. E., E. J. Bell, G. F. Mann, V. Murugesan, D. G. Smith, R. A. McCartney, and J. F. Mowbray. 1988. Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet i:146-150.
484. Yousef, G. E., I. N. Brown, and J. F. Mowbray. 1987. Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Intervirology 28:163-170.
485. Yousef, G. E., G. F. Mann, I. N. Brown, and J. F. Mowbray. 1987. Clinical and research application of an enterovirus group-reactive monoclonal antibody. Intervirology 28:199-205.
486. Zaaijer, H. L., H. T. M. Cuypers, H. W. Reesink. I. N. Winkel, G. Gerken, and P. N. Lelie. 1993. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341:722-724.
487. Zeuzem, S., B. Ruster, and W. K. Roth. 1994. Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus. Z. Gastroenterol. 32:342-347.
488. Zhang, G., G. Wilsden, N. J. Knowles, and J. W. McCauley. 1993. Complete nucleotide sequence of a coxsackie B5 virus and its relationship to swine vesicular disease virus. J. Gen. Virol. 74:845-853.
489. Zhang, H., N. W. Blake, X. Ouyang, Y. A. Pandolfino, P. Morgan-Capner, and L. C. Archard. 1995. A single amino acid substitution in the capsid protein VP1 of Coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model. Arch. Virol. 140:959-966.
490. Zhang, H. Y., G. E. Yousef, L. Cunningham, N. W. Blake, X. O. Yang, T. A. Bayston, R, Kandolf, and L. C. Archard. 1993. Attenuation of a reactivated cardiovirulent coxsackievirus B3: the 5′-nontranslated region does not contain major attenuation determinants. J. Med. Virol. 41:129-137.
491. Zhang, Z. X., Z. B. Yun, M. Chen, A. Sönnerborg, and M. Sällberg. 1995. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction. J. Med. Virol. 45:50-55.
492. Zheng, D.-P., L.-B. Zhang, Z.-Y. Fang, C.-F. Yang, M. Mulders, M. A. Pallansch, and O. M. Kew. 1993. Distribution of wild type 1 poliovirus genotypes in China. J. Infect. Dis. 168:1361-1367.
493. Zheng, Z.-M., P.-J. He, D. Caueffield, M. Neumann, S. Specter, C. C. Baker, and M. J. Bankowski. 1995. Enterovirus 71 isolated from China is serologically similar to the prototype E71 BrCr strain but differs in the 5′-noncoding region. J. Med. Virol. 47:161-167.
494. Zimmermann, H., H. J. Eggers, A. Zimmermann, W. Kraus, and B. Nelsensalz. 1995. Complete nucleotide sequence and biological properties of an infectious clone of prototype echovirus 9. Virus Res. 39:311-319.
495. Zoll, G. J., W. J. G. Melchers, H. Kopecka, G. Jambroes, H. J. A. van der Poel, and J. M. D. Galama. 1992. General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections. J. Clin. Microbiol. 30:160-165.
496. Zoll, J., J. Galama, and W. Melchers. 1994. Intratypic genome variability of the coxsackievirus B1 2A protease region. J. Gen. Virol. 75:687-692.